Datasets:

presencesw

/

mednli

like 0

23ec9d68-66c7-11e7-8c1e-f45c89b91419

contradiction

Came to ED complaining of vomiting and weakness.

Patient has negative ROS

(ROOT (NP (NP (NP (NNP Came)) (PP (TO to) (NP (NP (NNP ED)) (VP (VBG complaining) (PP (IN of) (NP (VBG vomiting) (CC and) (NP (NN weakness)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ negative) (NN ROS)))))

( ( Came ( to ( ED ( complaining ( of ( ( vomiting and ) weakness ) ) ) ) ) ) . )

( Patient ( has ( negative ROS ) ) )

23ec9f2c-66c7-11e7-8e44-f45c89b91419

neutral

Came to ED complaining of vomiting and weakness.

Patient has nausea

(ROOT (NP (NP (NP (NNP Came)) (PP (TO to) (NP (NP (NNP ED)) (VP (VBG complaining) (PP (IN of) (NP (VBG vomiting) (CC and) (NP (NN weakness)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN nausea)))))

( ( Came ( to ( ED ( complaining ( of ( ( vomiting and ) weakness ) ) ) ) ) ) . )

( Patient ( has nausea ) )

23eca0f6-66c7-11e7-b962-f45c89b91419

entailment

CAD: CAD s/p CABG (LIMA to LAD, SVG to OM) s/p PCI ([**3-4**]) 2.

patient has history of cabg

(ROOT (NP (NP (NNP CAD)) (: :) (NP (NP (NP (NN CAD) (NN s/p) (NN CABG)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP LIMA)) (PP (TO to) (NP (NN LAD)))) (, ,) (NP (NP (NNP SVG)) (PP (TO to) (NP (NNP OM))))) (-RRB- -RRB-))) (NP (NP (JJ s/p) (NN PCI)) (PRN (-LRB- -LRB-) (FRAG (-LRB- -LSB-) (QP (NP (SYM **) (CD 3-4) (X (SYM **)) (-RRB- -RSB-) (-RRB- -RRB-) (CD 2))))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (NP (NN history)) (PP (IN of) (NP (NN cabg)))))))

( ( ( CAD : ) ( ( ( CAD ( s/p CABG ) ) ( -LRB- ( ( ( ( LIMA ( to LAD ) ) , ) ( SVG ( to OM ) ) ) -RRB- ) ) ) ( ( s/p PCI ) ( -LRB- ( -LSB- ( ** ( 3-4 ( ** ( -RSB- ( -RRB- 2 ) ) ) ) ) ) ) ) ) ) . )

( patient ( has ( history ( of cabg ) ) ) )

23eca330-66c7-11e7-8d81-f45c89b91419

contradiction

CAD: CAD s/p CABG (LIMA to LAD, SVG to OM) s/p PCI ([**3-4**]) 2.

patient has no cardiac history

(ROOT (NP (NP (NNP CAD)) (: :) (NP (NP (NP (NN CAD) (NN s/p) (NN CABG)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP LIMA)) (PP (TO to) (NP (NN LAD)))) (, ,) (NP (NP (NNP SVG)) (PP (TO to) (NP (NNP OM))))) (-RRB- -RRB-))) (NP (NP (JJ s/p) (NN PCI)) (PRN (-LRB- -LRB-) (FRAG (-LRB- -LSB-) (QP (NP (SYM **) (CD 3-4) (X (SYM **)) (-RRB- -RSB-) (-RRB- -RRB-) (CD 2))))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (DT no) (JJ cardiac) (NN history)))))

( ( ( CAD : ) ( ( ( CAD ( s/p CABG ) ) ( -LRB- ( ( ( ( LIMA ( to LAD ) ) , ) ( SVG ( to OM ) ) ) -RRB- ) ) ) ( ( s/p PCI ) ( -LRB- ( -LSB- ( ** ( 3-4 ( ** ( -RSB- ( -RRB- 2 ) ) ) ) ) ) ) ) ) ) . )

( patient ( has ( no ( cardiac history ) ) ) )

23eca4fe-66c7-11e7-89c1-f45c89b91419

neutral

CAD: CAD s/p CABG (LIMA to LAD, SVG to OM) s/p PCI ([**3-4**]) 2.

patient has heart failure

(ROOT (NP (NP (NNP CAD)) (: :) (NP (NP (NP (NN CAD) (NN s/p) (NN CABG)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP LIMA)) (PP (TO to) (NP (NN LAD)))) (, ,) (NP (NP (NNP SVG)) (PP (TO to) (NP (NNP OM))))) (-RRB- -RRB-))) (NP (NP (JJ s/p) (NN PCI)) (PRN (-LRB- -LRB-) (FRAG (-LRB- -LSB-) (QP (NP (SYM **) (CD 3-4) (X (SYM **)) (-RRB- -RSB-) (-RRB- -RRB-) (CD 2))))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (NN heart) (NN failure)))))

( ( ( CAD : ) ( ( ( CAD ( s/p CABG ) ) ( -LRB- ( ( ( ( LIMA ( to LAD ) ) , ) ( SVG ( to OM ) ) ) -RRB- ) ) ) ( ( s/p PCI ) ( -LRB- ( -LSB- ( ** ( 3-4 ( ** ( -RSB- ( -RRB- 2 ) ) ) ) ) ) ) ) ) ) . )

( patient ( has ( heart failure ) ) )

23eca6f0-66c7-11e7-bed9-f45c89b91419

entailment

Underwent ORIF of R knee on [**11-19**] due to non-[**Hospital1 **]. - s/p repair of R ruptured patellar tendon in [**3227**] .

Patient has had trauma

(ROOT (NP (NP (NP (JJ Underwent) (NN ORIF)) (PP (IN of) (NP (NN R) (NN knee))) (PP (IN on) (PRN (-LRB- -LSB-) (S (NP (SYM **) (CD 11-19) (X (SYM **)) (-RRB- -RSB-)) (ADJP (JJ due) (TO to) (JJ non) (: -))))) (NP (-LRB- -LSB-) (SBAR (S (NP (NP (SYM **) (NN Hospital1) (X (SYM **)) (-RRB- -RSB-) (. .) (: -) (NN s/p) (NN repair)) (PP (IN of) (NP (NN R)))) (VP (VBD ruptured) (NP (NN patellar) (NN tendon)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 3227)) (X (SYM **))) (-RRB- -RSB-)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN had) (NP (NN trauma))))))

( ( ( ( ( Underwent ORIF ) ( of ( R knee ) ) ) ( on ( -LSB- ( ( ** ( ( 11-19 ** ) -RSB- ) ) ( due ( to ( non - ) ) ) ) ) ) ) ( -LSB- ( ( ( ** ( Hospital1 ( ** ( -RSB- ( . ( - ( s/p repair ) ) ) ) ) ) ) ( of R ) ) ( ( ruptured ( patellar tendon ) ) ( in ( -LSB- ( ( ** ( 3227 ** ) ) -RSB- ) ) ) ) ) ) ) . )

( Patient ( has ( had trauma ) ) )

23eca8ee-66c7-11e7-ac58-f45c89b91419

contradiction

Underwent ORIF of R knee on [**11-19**] due to non-[**Hospital1 **]. - s/p repair of R ruptured patellar tendon in [**3227**] .

Patient has no surgery

(ROOT (NP (NP (NP (JJ Underwent) (NN ORIF)) (PP (IN of) (NP (NN R) (NN knee))) (PP (IN on) (PRN (-LRB- -LSB-) (S (NP (SYM **) (CD 11-19) (X (SYM **)) (-RRB- -RSB-)) (ADJP (JJ due) (TO to) (JJ non) (: -))))) (NP (-LRB- -LSB-) (SBAR (S (NP (NP (SYM **) (NN Hospital1) (X (SYM **)) (-RRB- -RSB-) (. .) (: -) (NN s/p) (NN repair)) (PP (IN of) (NP (NN R)))) (VP (VBD ruptured) (NP (NN patellar) (NN tendon)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 3227)) (X (SYM **))) (-RRB- -RSB-)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NN surgery)))))

( ( ( ( ( Underwent ORIF ) ( of ( R knee ) ) ) ( on ( -LSB- ( ( ** ( ( 11-19 ** ) -RSB- ) ) ( due ( to ( non - ) ) ) ) ) ) ) ( -LSB- ( ( ( ** ( Hospital1 ( ** ( -RSB- ( . ( - ( s/p repair ) ) ) ) ) ) ) ( of R ) ) ( ( ruptured ( patellar tendon ) ) ( in ( -LSB- ( ( ** ( 3227 ** ) ) -RSB- ) ) ) ) ) ) ) . )

( Patient ( has ( no surgery ) ) )

23ecaae2-66c7-11e7-bea0-f45c89b91419

neutral

Underwent ORIF of R knee on [**11-19**] due to non-[**Hospital1 **]. - s/p repair of R ruptured patellar tendon in [**3227**] .

Patient has knee pain

(ROOT (NP (NP (NP (JJ Underwent) (NN ORIF)) (PP (IN of) (NP (NN R) (NN knee))) (PP (IN on) (PRN (-LRB- -LSB-) (S (NP (SYM **) (CD 11-19) (X (SYM **)) (-RRB- -RSB-)) (ADJP (JJ due) (TO to) (JJ non) (: -))))) (NP (-LRB- -LSB-) (SBAR (S (NP (NP (SYM **) (NN Hospital1) (X (SYM **)) (-RRB- -RSB-) (. .) (: -) (NN s/p) (NN repair)) (PP (IN of) (NP (NN R)))) (VP (VBD ruptured) (NP (NN patellar) (NN tendon)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 3227)) (X (SYM **))) (-RRB- -RSB-)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN knee) (NN pain)))))

( ( ( ( ( Underwent ORIF ) ( of ( R knee ) ) ) ( on ( -LSB- ( ( ** ( ( 11-19 ** ) -RSB- ) ) ( due ( to ( non - ) ) ) ) ) ) ) ( -LSB- ( ( ( ** ( Hospital1 ( ** ( -RSB- ( . ( - ( s/p repair ) ) ) ) ) ) ) ( of R ) ) ( ( ruptured ( patellar tendon ) ) ( in ( -LSB- ( ( ** ( 3227 ** ) ) -RSB- ) ) ) ) ) ) ) . )

( Patient ( has ( knee pain ) ) )

23ecad24-66c7-11e7-b910-f45c89b91419

entailment

Recurrent pleural effusion- unclear etiology, cytology negative in the past.

the patient has recurrent pleural effusions

(ROOT (NP (NP (JJ Recurrent) (JJ pleural) (NN effusion)) (: -) (NP (JJ unclear) (NN etiology)) (, ,) (NP (NP (NN cytology) (JJ negative)) (PP (IN in) (NP (DT the) (NN past)))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (JJ recurrent) (JJ pleural) (NNS effusions)))))

( ( ( ( ( ( Recurrent ( pleural effusion ) ) - ) ( unclear etiology ) ) , ) ( ( cytology negative ) ( in ( the past ) ) ) ) . )

( ( the patient ) ( has ( recurrent ( pleural effusions ) ) ) )

23ecaff6-66c7-11e7-ac22-f45c89b91419

contradiction

Recurrent pleural effusion- unclear etiology, cytology negative in the past.

the patient has no history of effusion

(ROOT (NP (NP (JJ Recurrent) (JJ pleural) (NN effusion)) (: -) (NP (JJ unclear) (NN etiology)) (, ,) (NP (NP (NN cytology) (JJ negative)) (PP (IN in) (NP (DT the) (NN past)))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NN effusion)))))))

( ( ( ( ( ( Recurrent ( pleural effusion ) ) - ) ( unclear etiology ) ) , ) ( ( cytology negative ) ( in ( the past ) ) ) ) . )

( ( the patient ) ( has ( ( no history ) ( of effusion ) ) ) )

23ecb578-66c7-11e7-a8db-f45c89b91419

neutral

Recurrent pleural effusion- unclear etiology, cytology negative in the past.

the patient has lung cancer

(ROOT (NP (NP (JJ Recurrent) (JJ pleural) (NN effusion)) (: -) (NP (JJ unclear) (NN etiology)) (, ,) (NP (NP (NN cytology) (JJ negative)) (PP (IN in) (NP (DT the) (NN past)))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NN lung) (NN cancer)))))

( ( ( ( ( ( Recurrent ( pleural effusion ) ) - ) ( unclear etiology ) ) , ) ( ( cytology negative ) ( in ( the past ) ) ) ) . )

( ( the patient ) ( has ( lung cancer ) ) )

23ecb79c-66c7-11e7-90da-f45c89b91419

entailment

age [**7-24**] ARF with arthritis, heart murmur. age 20 Hypertension, 4+ labile with some [**Month/Year (2) 21269**] of 200/100 for which he has gone to ED for control.

Multiple medical conditions

(ROOT (NP (NP (NP (NN age)) (PRN (-LRB- -LSB-) (NP (NP (NP (NP (SYM **) (CD 7-24) (X (SYM **)) (-RRB- -RSB-) (NN ARF)) (PP (IN with) (NP (NN arthritis)))) (, ,) (NP (NN heart) (NN murmur))) (. .) (NP (NP (NN age) (CD 20)) (NN Hypertension)) (, ,) (ADJP (CD 4) (CC +) (JJ labile) (PP (IN with) (NP (NP (DT some) (PRN (-LRB- -LSB-) (NP (SYM **) (NN Month/Year) (-LRB- -LRB-) (CD 2) (-RRB- -RRB-) (CD 21269) (SYM **)) (-RRB- -RSB-))) (PP (IN of) (NP (CD 200/100)))))) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (PRP he)) (VP (VBZ has) (VP (VBN gone) (PP (TO to) (NP (NP (NNP ED)) (PP (IN for) (NP (NN control)))))))))))) (. .)))

(ROOT (NP (JJ Multiple) (JJ medical) (NNS conditions)))

( ( age ( -LSB- ( ( ( ( ( ( ( ( ( ** ( 7-24 ( ** ( -RSB- ARF ) ) ) ) ( with arthritis ) ) , ) ( heart murmur ) ) . ) ( ( age 20 ) Hypertension ) ) , ) ( ( ( 4 + ) labile ) ( with ( ( some ( -LSB- ( ( ** ( ( ( ( ( Month/Year -LRB- ) 2 ) -RRB- ) 21269 ) ** ) ) -RSB- ) ) ) ( of 200/100 ) ) ) ) ) ( ( for which ) ( he ( has ( gone ( to ( ED ( for control ) ) ) ) ) ) ) ) ) ) . )

( Multiple ( medical conditions ) )

23ecb9da-66c7-11e7-b902-f45c89b91419

contradiction

age [**7-24**] ARF with arthritis, heart murmur. age 20 Hypertension, 4+ labile with some [**Month/Year (2) 21269**] of 200/100 for which he has gone to ED for control.

Cardiac function is normal

(ROOT (NP (NP (NP (NN age)) (PRN (-LRB- -LSB-) (NP (NP (NP (NP (SYM **) (CD 7-24) (X (SYM **)) (-RRB- -RSB-) (NN ARF)) (PP (IN with) (NP (NN arthritis)))) (, ,) (NP (NN heart) (NN murmur))) (. .) (NP (NP (NN age) (CD 20)) (NN Hypertension)) (, ,) (ADJP (CD 4) (CC +) (JJ labile) (PP (IN with) (NP (NP (DT some) (PRN (-LRB- -LSB-) (NP (SYM **) (NN Month/Year) (-LRB- -LRB-) (CD 2) (-RRB- -RRB-) (CD 21269) (SYM **)) (-RRB- -RSB-))) (PP (IN of) (NP (CD 200/100)))))) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (PRP he)) (VP (VBZ has) (VP (VBN gone) (PP (TO to) (NP (NP (NNP ED)) (PP (IN for) (NP (NN control)))))))))))) (. .)))

(ROOT (S (NP (JJ Cardiac) (NN function)) (VP (VBZ is) (ADJP (JJ normal)))))

( ( age ( -LSB- ( ( ( ( ( ( ( ( ( ** ( 7-24 ( ** ( -RSB- ARF ) ) ) ) ( with arthritis ) ) , ) ( heart murmur ) ) . ) ( ( age 20 ) Hypertension ) ) , ) ( ( ( 4 + ) labile ) ( with ( ( some ( -LSB- ( ( ** ( ( ( ( ( Month/Year -LRB- ) 2 ) -RRB- ) 21269 ) ** ) ) -RSB- ) ) ) ( of 200/100 ) ) ) ) ) ( ( for which ) ( he ( has ( gone ( to ( ED ( for control ) ) ) ) ) ) ) ) ) ) . )

( ( Cardiac function ) ( is normal ) )

23ecbc76-66c7-11e7-bf1e-f45c89b91419

neutral

age [**7-24**] ARF with arthritis, heart murmur. age 20 Hypertension, 4+ labile with some [**Month/Year (2) 21269**] of 200/100 for which he has gone to ED for control.

On anti-hypertensive medication

(ROOT (NP (NP (NP (NN age)) (PRN (-LRB- -LSB-) (NP (NP (NP (NP (SYM **) (CD 7-24) (X (SYM **)) (-RRB- -RSB-) (NN ARF)) (PP (IN with) (NP (NN arthritis)))) (, ,) (NP (NN heart) (NN murmur))) (. .) (NP (NP (NN age) (CD 20)) (NN Hypertension)) (, ,) (ADJP (CD 4) (CC +) (JJ labile) (PP (IN with) (NP (NP (DT some) (PRN (-LRB- -LSB-) (NP (SYM **) (NN Month/Year) (-LRB- -LRB-) (CD 2) (-RRB- -RRB-) (CD 21269) (SYM **)) (-RRB- -RSB-))) (PP (IN of) (NP (CD 200/100)))))) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (PRP he)) (VP (VBZ has) (VP (VBN gone) (PP (TO to) (NP (NP (NNP ED)) (PP (IN for) (NP (NN control)))))))))))) (. .)))

(ROOT (PP (IN On) (NP (JJ anti-hypertensive) (NN medication))))

( ( age ( -LSB- ( ( ( ( ( ( ( ( ( ** ( 7-24 ( ** ( -RSB- ARF ) ) ) ) ( with arthritis ) ) , ) ( heart murmur ) ) . ) ( ( age 20 ) Hypertension ) ) , ) ( ( ( 4 + ) labile ) ( with ( ( some ( -LSB- ( ( ** ( ( ( ( ( Month/Year -LRB- ) 2 ) -RRB- ) 21269 ) ** ) ) -RSB- ) ) ) ( of 200/100 ) ) ) ) ) ( ( for which ) ( he ( has ( gone ( to ( ED ( for control ) ) ) ) ) ) ) ) ) ) . )

( On ( anti-hypertensive medication ) )

23ecbe38-66c7-11e7-b474-f45c89b91419

entailment

She denied any loss of consciousness or focal pain.

She was awake and alert

(ROOT (S (NP (PRP She)) (VP (VBD denied) (NP (NP (DT any) (NN loss)) (PP (IN of) (NP (NP (NN consciousness)) (CC or) (NP (JJ focal) (NN pain)))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBD was) (ADJP (ADJP (JJ awake)) (CC and) (ADJP (JJ alert))))))

( She ( ( denied ( ( any loss ) ( of ( ( consciousness or ) ( focal pain ) ) ) ) ) . ) )

( She ( was ( ( awake and ) alert ) ) )

23ecbfd2-66c7-11e7-a2b5-f45c89b91419

contradiction

She denied any loss of consciousness or focal pain.

She is unconscious

(ROOT (S (NP (PRP She)) (VP (VBD denied) (NP (NP (DT any) (NN loss)) (PP (IN of) (NP (NP (NN consciousness)) (CC or) (NP (JJ focal) (NN pain)))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ is) (ADJP (JJ unconscious)))))

( She ( ( denied ( ( any loss ) ( of ( ( consciousness or ) ( focal pain ) ) ) ) ) . ) )

( She ( is unconscious ) )

23ecc2ca-66c7-11e7-bc15-f45c89b91419

neutral

She denied any loss of consciousness or focal pain.

She has a history of head trauma

(ROOT (S (NP (PRP She)) (VP (VBD denied) (NP (NP (DT any) (NN loss)) (PP (IN of) (NP (NP (NN consciousness)) (CC or) (NP (JJ focal) (NN pain)))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN head) (NN trauma)))))))

( She ( ( denied ( ( any loss ) ( of ( ( consciousness or ) ( focal pain ) ) ) ) ) . ) )

( She ( has ( ( a history ) ( of ( head trauma ) ) ) ) )

23ecc4d2-66c7-11e7-a899-f45c89b91419

entailment

83 yo female w/ PMHX sig for HTN, CHF w/ diastolic dysfunction, right renal artery stenosis p/w increased lethargy and unresponsiveness for 1 day.

The patient has a cardiac condition.

(ROOT (NP (NP (NP (CD 83) (NN yo) (JJ female) (NN w)) (: /) (NP (NP (NNP PMHX) (NN sig)) (PP (IN for) (NP (NN HTN)))) (, ,) (NP (NN CHF) (NN w)) (NP (: /) (JJ diastolic) (NN dysfunction)) (, ,) (NP (JJ right) (JJ renal) (NN artery) (NN stenosis) (NN p/w)) (NP (NP (VBD increased) (NN lethargy) (CC and) (NN unresponsiveness)) (PP (IN for) (NP (CD 1) (NN day))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ cardiac) (NN condition))) (. .)))

( ( ( ( ( ( ( ( ( ( 83 ( yo ( female w ) ) ) / ) ( ( PMHX sig ) ( for HTN ) ) ) , ) ( CHF w ) ) ( / ( diastolic dysfunction ) ) ) , ) ( right ( renal ( artery ( stenosis p/w ) ) ) ) ) ( ( increased ( ( lethargy and ) unresponsiveness ) ) ( for ( 1 day ) ) ) ) . )

( ( The patient ) ( ( has ( a ( cardiac condition ) ) ) . ) )

23ecc75c-66c7-11e7-aea5-f45c89b91419

contradiction

83 yo female w/ PMHX sig for HTN, CHF w/ diastolic dysfunction, right renal artery stenosis p/w increased lethargy and unresponsiveness for 1 day.

The patient has a normal functioning heart.

(ROOT (NP (NP (NP (CD 83) (NN yo) (JJ female) (NN w)) (: /) (NP (NP (NNP PMHX) (NN sig)) (PP (IN for) (NP (NN HTN)))) (, ,) (NP (NN CHF) (NN w)) (NP (: /) (JJ diastolic) (NN dysfunction)) (, ,) (NP (JJ right) (JJ renal) (NN artery) (NN stenosis) (NN p/w)) (NP (NP (VBD increased) (NN lethargy) (CC and) (NN unresponsiveness)) (PP (IN for) (NP (CD 1) (NN day))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ normal) (VBG functioning) (NN heart))) (. .)))

( ( ( ( ( ( ( ( ( ( 83 ( yo ( female w ) ) ) / ) ( ( PMHX sig ) ( for HTN ) ) ) , ) ( CHF w ) ) ( / ( diastolic dysfunction ) ) ) , ) ( right ( renal ( artery ( stenosis p/w ) ) ) ) ) ( ( increased ( ( lethargy and ) unresponsiveness ) ) ( for ( 1 day ) ) ) ) . )

( ( The patient ) ( ( has ( a ( normal ( functioning heart ) ) ) ) . ) )

23ecc96e-66c7-11e7-b420-f45c89b91419

neutral

83 yo female w/ PMHX sig for HTN, CHF w/ diastolic dysfunction, right renal artery stenosis p/w increased lethargy and unresponsiveness for 1 day.

The patient developed diastolic dysfunction from longstanding hypertension.

(ROOT (NP (NP (NP (CD 83) (NN yo) (JJ female) (NN w)) (: /) (NP (NP (NNP PMHX) (NN sig)) (PP (IN for) (NP (NN HTN)))) (, ,) (NP (NN CHF) (NN w)) (NP (: /) (JJ diastolic) (NN dysfunction)) (, ,) (NP (JJ right) (JJ renal) (NN artery) (NN stenosis) (NN p/w)) (NP (NP (VBD increased) (NN lethargy) (CC and) (NN unresponsiveness)) (PP (IN for) (NP (CD 1) (NN day))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD developed) (NP (NP (JJ diastolic) (NN dysfunction)) (PP (IN from) (NP (JJ longstanding) (NN hypertension))))) (. .)))

( ( ( ( ( ( ( ( ( ( 83 ( yo ( female w ) ) ) / ) ( ( PMHX sig ) ( for HTN ) ) ) , ) ( CHF w ) ) ( / ( diastolic dysfunction ) ) ) , ) ( right ( renal ( artery ( stenosis p/w ) ) ) ) ) ( ( increased ( ( lethargy and ) unresponsiveness ) ) ( for ( 1 day ) ) ) ) . )

( ( The patient ) ( ( developed ( ( diastolic dysfunction ) ( from ( longstanding hypertension ) ) ) ) . ) )

23eccb4c-66c7-11e7-87f8-f45c89b91419

entailment

States the pain was similar to that she had when she had her [** Location **]us MI's.

Patient has a significant cardiac history

(ROOT (S (NP (NNPS States)) (NP (DT the) (NN pain)) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (SBAR (S (NP (PRP she)) (VP (VBD had) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD had) (NP (PRP$ her) (-LRB- -LSB-) (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-) (PRP us) (NP (NNP MI) (POS 's))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (JJ significant) (JJ cardiac) (NN history)))))

( States ( ( the pain ) ( ( was ( similar ( to ( that ( she ( had ( when ( she ( had ( her ( -LSB- ( ** ( ( ( ( Location ** ) -RSB- ) us ) ( MI 's ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) ) )

( Patient ( has ( a ( significant ( cardiac history ) ) ) ) )

23eccd1a-66c7-11e7-9c3d-f45c89b91419

contradiction

States the pain was similar to that she had when she had her [** Location **]us MI's.

Patient has normal EKG

(ROOT (S (NP (NNPS States)) (NP (DT the) (NN pain)) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (SBAR (S (NP (PRP she)) (VP (VBD had) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD had) (NP (PRP$ her) (-LRB- -LSB-) (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-) (PRP us) (NP (NNP MI) (POS 's))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ normal) (NNP EKG)))))

( States ( ( the pain ) ( ( was ( similar ( to ( that ( she ( had ( when ( she ( had ( her ( -LSB- ( ** ( ( ( ( Location ** ) -RSB- ) us ) ( MI 's ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) ) )

( Patient ( has ( normal EKG ) ) )

23ecced2-66c7-11e7-9265-f45c89b91419

neutral

States the pain was similar to that she had when she had her [** Location **]us MI's.

Patient has elevated troponin

(ROOT (S (NP (NNPS States)) (NP (DT the) (NN pain)) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (SBAR (S (NP (PRP she)) (VP (VBD had) (SBAR (WHADVP (WRB when)) (S (NP (PRP she)) (VP (VBD had) (NP (PRP$ her) (-LRB- -LSB-) (SYM **) (NNP Location) (X (SYM **)) (-RRB- -RSB-) (PRP us) (NP (NNP MI) (POS 's))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ elevated) (NN troponin)))))

( States ( ( the pain ) ( ( was ( similar ( to ( that ( she ( had ( when ( she ( had ( her ( -LSB- ( ** ( ( ( ( Location ** ) -RSB- ) us ) ( MI 's ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) ) )

( Patient ( has ( elevated troponin ) ) )

23ecd0c8-66c7-11e7-af03-f45c89b91419

entailment

47 year old female with HepC/Cirrhosis on liver [**Month/Day/Year 1222**] list, referred for abnormal labs, WBC of 77K on [**7-7**].

The patient has findings consistent with an infection.

(ROOT (NP (NP (NP (CD 47) (NN year) (JJ old) (NN female)) (PP (IN with) (NP (NP (NN HepC/Cirrhosis)) (PP (IN on) (NP (NN liver)))))) (FRAG (-LRB- -LSB-) (PP (SYM **) (NP (NP (NNP Month/Day/Year) (CD 1222)) (PP (X (SYM **)) (NP (NP (-RRB- -RSB-) (NN list)) (, ,) (VP (VBN referred) (PP (IN for) (NP (JJ abnormal) (NNS labs)))) (, ,) (NP (NP (NNP WBC)) (PP (IN of) (NP (NNP 77K))) (PP (IN on) (PRN (-LRB- -LSB-) (NP (SYM **) (CD 7-7) (X (SYM **)) (-RRB- -RSB-)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (NNS findings)) (ADJP (JJ consistent) (PP (IN with) (NP (DT an) (NN infection)))))) (. .)))

( ( ( ( 47 ( year ( old female ) ) ) ( with ( HepC/Cirrhosis ( on liver ) ) ) ) ( -LSB- ( ** ( ( Month/Day/Year 1222 ) ( ** ( ( ( ( ( -RSB- list ) , ) ( referred ( for ( abnormal labs ) ) ) ) , ) ( ( WBC ( of 77K ) ) ( on ( -LSB- ( ** ( ( 7-7 ** ) -RSB- ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( findings ( consistent ( with ( an infection ) ) ) ) ) . ) )

23ecd3ca-66c7-11e7-af60-f45c89b91419

contradiction

47 year old female with HepC/Cirrhosis on liver [**Month/Day/Year 1222**] list, referred for abnormal labs, WBC of 77K on [**7-7**].

The patient has no findings consistent with infection.

(ROOT (NP (NP (NP (CD 47) (NN year) (JJ old) (NN female)) (PP (IN with) (NP (NP (NN HepC/Cirrhosis)) (PP (IN on) (NP (NN liver)))))) (FRAG (-LRB- -LSB-) (PP (SYM **) (NP (NP (NNP Month/Day/Year) (CD 1222)) (PP (X (SYM **)) (NP (NP (-RRB- -RSB-) (NN list)) (, ,) (VP (VBN referred) (PP (IN for) (NP (JJ abnormal) (NNS labs)))) (, ,) (NP (NP (NNP WBC)) (PP (IN of) (NP (NNP 77K))) (PP (IN on) (PRN (-LRB- -LSB-) (NP (SYM **) (CD 7-7) (X (SYM **)) (-RRB- -RSB-)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT no) (NNS findings)) (ADJP (JJ consistent) (PP (IN with) (NP (NN infection)))))) (. .)))

( ( ( ( 47 ( year ( old female ) ) ) ( with ( HepC/Cirrhosis ( on liver ) ) ) ) ( -LSB- ( ** ( ( Month/Day/Year 1222 ) ( ** ( ( ( ( ( -RSB- list ) , ) ( referred ( for ( abnormal labs ) ) ) ) , ) ( ( WBC ( of 77K ) ) ( on ( -LSB- ( ** ( ( 7-7 ** ) -RSB- ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( ( no findings ) ( consistent ( with infection ) ) ) ) . ) )

23ecd5f6-66c7-11e7-a1b3-f45c89b91419

neutral

47 year old female with HepC/Cirrhosis on liver [**Month/Day/Year 1222**] list, referred for abnormal labs, WBC of 77K on [**7-7**].

The patient has spontaneous bacterial peritonitis.

(ROOT (NP (NP (NP (CD 47) (NN year) (JJ old) (NN female)) (PP (IN with) (NP (NP (NN HepC/Cirrhosis)) (PP (IN on) (NP (NN liver)))))) (FRAG (-LRB- -LSB-) (PP (SYM **) (NP (NP (NNP Month/Day/Year) (CD 1222)) (PP (X (SYM **)) (NP (NP (-RRB- -RSB-) (NN list)) (, ,) (VP (VBN referred) (PP (IN for) (NP (JJ abnormal) (NNS labs)))) (, ,) (NP (NP (NNP WBC)) (PP (IN of) (NP (NNP 77K))) (PP (IN on) (PRN (-LRB- -LSB-) (NP (SYM **) (CD 7-7) (X (SYM **)) (-RRB- -RSB-)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ spontaneous) (JJ bacterial) (NN peritonitis))) (. .)))

( ( ( ( 47 ( year ( old female ) ) ) ( with ( HepC/Cirrhosis ( on liver ) ) ) ) ( -LSB- ( ** ( ( Month/Day/Year 1222 ) ( ** ( ( ( ( ( -RSB- list ) , ) ( referred ( for ( abnormal labs ) ) ) ) , ) ( ( WBC ( of 77K ) ) ( on ( -LSB- ( ** ( ( 7-7 ** ) -RSB- ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( spontaneous ( bacterial peritonitis ) ) ) . ) )

23ecd850-66c7-11e7-aff9-f45c89b91419

entailment

Mother presented on [**12-15**] with vaginal bleeding with a large clot seen on ultrasound.

Patient had abnormal bleeding and ultrasound

(ROOT (S (NP (NNP Mother)) (VP (VBD presented) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 12-15) (X (SYM **)) (S (VP (-RRB- -RSB-) (PP (IN with) (NP (JJ vaginal) (NN bleeding))) (PP (IN with) (NP (NP (DT a) (JJ large) (NNS clot)) (VP (VBN seen) (PP (IN on) (NP (NN ultrasound))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBD had) (NP (NP (JJ abnormal) (NN bleeding)) (CC and) (NP (NN ultrasound))))))

( Mother ( ( presented ( on ( -LSB- ( ** ( ( 12-15 ** ) ( -RSB- ( ( with ( vaginal bleeding ) ) ( with ( ( a ( large clot ) ) ( seen ( on ultrasound ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( had ( ( ( abnormal bleeding ) and ) ultrasound ) ) )

23ecda26-66c7-11e7-8f0c-f45c89b91419

contradiction

Mother presented on [**12-15**] with vaginal bleeding with a large clot seen on ultrasound.

Ultrasound was unremarkable

(ROOT (S (NP (NNP Mother)) (VP (VBD presented) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 12-15) (X (SYM **)) (S (VP (-RRB- -RSB-) (PP (IN with) (NP (JJ vaginal) (NN bleeding))) (PP (IN with) (NP (NP (DT a) (JJ large) (NNS clot)) (VP (VBN seen) (PP (IN on) (NP (NN ultrasound))))))))))) (. .)))

(ROOT (S (NP (NN Ultrasound)) (VP (VBD was) (ADJP (JJ unremarkable)))))

( Mother ( ( presented ( on ( -LSB- ( ** ( ( 12-15 ** ) ( -RSB- ( ( with ( vaginal bleeding ) ) ( with ( ( a ( large clot ) ) ( seen ( on ultrasound ) ) ) ) ) ) ) ) ) ) ) . ) )

( Ultrasound ( was unremarkable ) )

23ecdbe8-66c7-11e7-8728-f45c89b91419

neutral

Mother presented on [**12-15**] with vaginal bleeding with a large clot seen on ultrasound.

Patient complained of pelvic pain

(ROOT (S (NP (NNP Mother)) (VP (VBD presented) (PP (IN on) (NP (-LRB- -LSB-) (SYM **) (CD 12-15) (X (SYM **)) (S (VP (-RRB- -RSB-) (PP (IN with) (NP (JJ vaginal) (NN bleeding))) (PP (IN with) (NP (NP (DT a) (JJ large) (NNS clot)) (VP (VBN seen) (PP (IN on) (NP (NN ultrasound))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBD complained) (PP (IN of) (NP (JJ pelvic) (NN pain))))))

( Mother ( ( presented ( on ( -LSB- ( ** ( ( 12-15 ** ) ( -RSB- ( ( with ( vaginal bleeding ) ) ( with ( ( a ( large clot ) ) ( seen ( on ultrasound ) ) ) ) ) ) ) ) ) ) ) . ) )

( Patient ( complained ( of ( pelvic pain ) ) ) )

23ecdddc-66c7-11e7-8b73-f45c89b91419

entailment

When she arrived in ED, VS showed SBP in 70s, 02 sats 97%, HR 68 Labetalol stopped and given IVFs with return of SBPS to 90s-100s.

The patient has a past medical history of hypertension.

(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (PRP she)) (VP (VBD arrived) (PP (IN in) (NP (NNP ED)))))) (, ,) (NP (NNP VS)) (VP (VBD showed) (NP (NNP SBP)) (PP (IN in) (NP (NP (CD 70s)) (, ,) (NP (CD 02)) (NP (NNS sats)))) (NP (NP (CD 97) (NN %)) (, ,) (NP (NP (NN HR) (CD 68) (NN Labetalol)) (VP (VBD stopped) (CC and) (VP (VBN given) (NP (NNS IVFs)) (PP (IN with) (NP (NP (NN return)) (PP (IN of) (NP (NN SBPS))) (PP (TO to) (NP (CD 90s-100s)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (JJ past) (JJ medical) (NN history)) (PP (IN of) (NP (NN hypertension))))) (. .)))

( ( When ( she ( arrived ( in ED ) ) ) ) ( , ( VS ( ( ( ( showed SBP ) ( in ( ( ( 70s , ) 02 ) sats ) ) ) ( ( ( 97 % ) , ) ( ( HR ( 68 Labetalol ) ) ( ( stopped and ) ( ( given IVFs ) ( with ( ( return ( of SBPS ) ) ( to 90s-100s ) ) ) ) ) ) ) ) . ) ) ) )

( ( The patient ) ( ( has ( ( a ( past ( medical history ) ) ) ( of hypertension ) ) ) . ) )

23ecdfd0-66c7-11e7-93c5-f45c89b91419

contradiction

When she arrived in ED, VS showed SBP in 70s, 02 sats 97%, HR 68 Labetalol stopped and given IVFs with return of SBPS to 90s-100s.

The patient does not take any medications.

(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (PRP she)) (VP (VBD arrived) (PP (IN in) (NP (NNP ED)))))) (, ,) (NP (NNP VS)) (VP (VBD showed) (NP (NNP SBP)) (PP (IN in) (NP (NP (CD 70s)) (, ,) (NP (CD 02)) (NP (NNS sats)))) (NP (NP (CD 97) (NN %)) (, ,) (NP (NP (NN HR) (CD 68) (NN Labetalol)) (VP (VBD stopped) (CC and) (VP (VBN given) (NP (NNS IVFs)) (PP (IN with) (NP (NP (NN return)) (PP (IN of) (NP (NN SBPS))) (PP (TO to) (NP (CD 90s-100s)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ does) (RB not) (VP (VB take) (NP (DT any) (NNS medications)))) (. .)))

( ( When ( she ( arrived ( in ED ) ) ) ) ( , ( VS ( ( ( ( showed SBP ) ( in ( ( ( 70s , ) 02 ) sats ) ) ) ( ( ( 97 % ) , ) ( ( HR ( 68 Labetalol ) ) ( ( stopped and ) ( ( given IVFs ) ( with ( ( return ( of SBPS ) ) ( to 90s-100s ) ) ) ) ) ) ) ) . ) ) ) )

( ( The patient ) ( ( ( does not ) ( take ( any medications ) ) ) . ) )

23ece2b4-66c7-11e7-b537-f45c89b91419

neutral

When she arrived in ED, VS showed SBP in 70s, 02 sats 97%, HR 68 Labetalol stopped and given IVFs with return of SBPS to 90s-100s.

The patient had an overdose of labetalol.

(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (PRP she)) (VP (VBD arrived) (PP (IN in) (NP (NNP ED)))))) (, ,) (NP (NNP VS)) (VP (VBD showed) (NP (NNP SBP)) (PP (IN in) (NP (NP (CD 70s)) (, ,) (NP (CD 02)) (NP (NNS sats)))) (NP (NP (CD 97) (NN %)) (, ,) (NP (NP (NN HR) (CD 68) (NN Labetalol)) (VP (VBD stopped) (CC and) (VP (VBN given) (NP (NNS IVFs)) (PP (IN with) (NP (NP (NN return)) (PP (IN of) (NP (NN SBPS))) (PP (TO to) (NP (CD 90s-100s)))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT an) (NN overdose)) (PP (IN of) (NP (NN labetalol))))) (. .)))

( ( When ( she ( arrived ( in ED ) ) ) ) ( , ( VS ( ( ( ( showed SBP ) ( in ( ( ( 70s , ) 02 ) sats ) ) ) ( ( ( 97 % ) , ) ( ( HR ( 68 Labetalol ) ) ( ( stopped and ) ( ( given IVFs ) ( with ( ( return ( of SBPS ) ) ( to 90s-100s ) ) ) ) ) ) ) ) . ) ) ) )

( ( The patient ) ( ( had ( ( an overdose ) ( of labetalol ) ) ) . ) )

23ece480-66c7-11e7-a936-f45c89b91419

entailment

Total cardiopulmonary bypass time was 113 minutes.

Patient has had a CABG

(ROOT (S (NP (JJ Total) (JJ cardiopulmonary) (NN bypass) (NN time)) (VP (VBD was) (NP (CD 113) (NNS minutes))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN had) (NP (DT a) (NN CABG))))))

( ( Total ( cardiopulmonary ( bypass time ) ) ) ( ( was ( 113 minutes ) ) . ) )

( Patient ( has ( had ( a CABG ) ) ) )

23ece612-66c7-11e7-9ec4-f45c89b91419

contradiction

Total cardiopulmonary bypass time was 113 minutes.

Patient has no CAD

(ROOT (S (NP (JJ Total) (JJ cardiopulmonary) (NN bypass) (NN time)) (VP (VBD was) (NP (CD 113) (NNS minutes))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT no) (NN CAD)))))

( ( Total ( cardiopulmonary ( bypass time ) ) ) ( ( was ( 113 minutes ) ) . ) )

( Patient ( has ( no CAD ) ) )

23ece794-66c7-11e7-8f2a-f45c89b91419

neutral

Total cardiopulmonary bypass time was 113 minutes.

Patient has PAD

(ROOT (S (NP (JJ Total) (JJ cardiopulmonary) (NN bypass) (NN time)) (VP (VBD was) (NP (CD 113) (NNS minutes))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN PAD)))))

( ( Total ( cardiopulmonary ( bypass time ) ) ) ( ( was ( 113 minutes ) ) . ) )

( Patient ( has PAD ) )

23ecec52-66c7-11e7-85a2-f45c89b91419

entailment

The patient was subsequently started on Levophed at 0.03mcg/kg/min.

The patient was started on Norepinephrine

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB subsequently)) (VP (VBN started) (PP (IN on) (NP (NNP Levophed))) (PP (IN at) (NP (CD 0.03) (NN mcg/kg/min))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NN Norepinephrine)))))))

( ( The patient ) ( ( ( was subsequently ) ( ( started ( on Levophed ) ) ( at ( 0.03 mcg/kg/min ) ) ) ) . ) )

( ( The patient ) ( was ( started ( on Norepinephrine ) ) ) )

23ecee12-66c7-11e7-b589-f45c89b91419

contradiction

The patient was subsequently started on Levophed at 0.03mcg/kg/min.

The patient had no indication for Norepinephrine

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB subsequently)) (VP (VBN started) (PP (IN on) (NP (NNP Levophed))) (PP (IN at) (NP (CD 0.03) (NN mcg/kg/min))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT no) (NN indication)) (PP (IN for) (NP (NN Norepinephrine)))))))

( ( The patient ) ( ( ( was subsequently ) ( ( started ( on Levophed ) ) ( at ( 0.03 mcg/kg/min ) ) ) ) . ) )

( ( The patient ) ( had ( ( no indication ) ( for Norepinephrine ) ) ) )

23ecf042-66c7-11e7-bad6-f45c89b91419

neutral

The patient was subsequently started on Levophed at 0.03mcg/kg/min.

The patient has septic shock

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB subsequently)) (VP (VBN started) (PP (IN on) (NP (NNP Levophed))) (PP (IN at) (NP (CD 0.03) (NN mcg/kg/min))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ septic) (NN shock)))))

( ( The patient ) ( ( ( was subsequently ) ( ( started ( on Levophed ) ) ( at ( 0.03 mcg/kg/min ) ) ) ) . ) )

( ( The patient ) ( has ( septic shock ) ) )

23ecf25e-66c7-11e7-8db0-f45c89b91419

entailment

Baby girl [**Known patient lastname 39746**] was born by a repeat scheduled cesarean section with an Apgar score of 4 at one minute, 5 at five minutes, and 7 at ten minutes.

The patient has had concerning apgars.

(ROOT (S (NP (NNP Baby) (NN girl) (-LRB- -LSB-) (SYM **) (VBN Known) (NN patient) (JJ lastname) (CD 39746) (SYM **)) (-RRB- -RSB-) (VP (VBD was) (VP (VBN born) (PP (IN by) (NP (NP (NP (DT a) (NN repeat)) (VBN scheduled) (JJ cesarean) (NN section)) (PP (IN with) (NP (NP (DT an) (JJ Apgar) (NN score)) (PP (IN of) (NP (CD 4))) (PP (IN at) (NP (CD one) (NN minute))))))))) (, ,) (NP (CD 5) (PP (PP (IN at) (NP (CD five) (NNS minutes))) (, ,) (CC and) (NP (CD 7))) (PP (IN at) (NP (CD ten) (NNS minutes)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (VP (VBN had) (S (VP (VBG concerning) (NP (NNS apgars)))))) (. .)))

( ( Baby ( girl ( -LSB- ( ** ( Known ( ( ( patient lastname ) 39746 ) ** ) ) ) ) ) ) ( -RSB- ( ( ( ( was ( born ( by ( ( ( a repeat ) ( scheduled ( cesarean section ) ) ) ( with ( ( ( an ( Apgar score ) ) ( of 4 ) ) ( at ( one minute ) ) ) ) ) ) ) ) , ) ( ( 5 ( ( ( ( at ( five minutes ) ) , ) and ) 7 ) ) ( at ( ten minutes ) ) ) ) . ) ) )

( ( The patient ) ( ( has ( had ( concerning apgars ) ) ) . ) )

23ecf478-66c7-11e7-b780-f45c89b91419

contradiction

Baby girl [**Known patient lastname 39746**] was born by a repeat scheduled cesarean section with an Apgar score of 4 at one minute, 5 at five minutes, and 7 at ten minutes.

The baby had reassuring apgars.

(ROOT (S (NP (NNP Baby) (NN girl) (-LRB- -LSB-) (SYM **) (VBN Known) (NN patient) (JJ lastname) (CD 39746) (SYM **)) (-RRB- -RSB-) (VP (VBD was) (VP (VBN born) (PP (IN by) (NP (NP (NP (DT a) (NN repeat)) (VBN scheduled) (JJ cesarean) (NN section)) (PP (IN with) (NP (NP (DT an) (JJ Apgar) (NN score)) (PP (IN of) (NP (CD 4))) (PP (IN at) (NP (CD one) (NN minute))))))))) (, ,) (NP (CD 5) (PP (PP (IN at) (NP (CD five) (NNS minutes))) (, ,) (CC and) (NP (CD 7))) (PP (IN at) (NP (CD ten) (NNS minutes)))) (. .)))

(ROOT (S (NP (DT The) (NN baby)) (VP (VBD had) (NP (JJ reassuring) (NNS apgars))) (. .)))

( ( Baby ( girl ( -LSB- ( ** ( Known ( ( ( patient lastname ) 39746 ) ** ) ) ) ) ) ) ( -RSB- ( ( ( ( was ( born ( by ( ( ( a repeat ) ( scheduled ( cesarean section ) ) ) ( with ( ( ( an ( Apgar score ) ) ( of 4 ) ) ( at ( one minute ) ) ) ) ) ) ) ) , ) ( ( 5 ( ( ( ( at ( five minutes ) ) , ) and ) 7 ) ) ( at ( ten minutes ) ) ) ) . ) ) )

( ( The baby ) ( ( had ( reassuring apgars ) ) . ) )

23ecf7a4-66c7-11e7-ac47-f45c89b91419

neutral

Baby girl [**Known patient lastname 39746**] was born by a repeat scheduled cesarean section with an Apgar score of 4 at one minute, 5 at five minutes, and 7 at ten minutes.

The patient was born premature.

(ROOT (S (NP (NNP Baby) (NN girl) (-LRB- -LSB-) (SYM **) (VBN Known) (NN patient) (JJ lastname) (CD 39746) (SYM **)) (-RRB- -RSB-) (VP (VBD was) (VP (VBN born) (PP (IN by) (NP (NP (NP (DT a) (NN repeat)) (VBN scheduled) (JJ cesarean) (NN section)) (PP (IN with) (NP (NP (DT an) (JJ Apgar) (NN score)) (PP (IN of) (NP (CD 4))) (PP (IN at) (NP (CD one) (NN minute))))))))) (, ,) (NP (CD 5) (PP (PP (IN at) (NP (CD five) (NNS minutes))) (, ,) (CC and) (NP (CD 7))) (PP (IN at) (NP (CD ten) (NNS minutes)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN born) (S (ADJP (JJ premature))))) (. .)))

( ( Baby ( girl ( -LSB- ( ** ( Known ( ( ( patient lastname ) 39746 ) ** ) ) ) ) ) ) ( -RSB- ( ( ( ( was ( born ( by ( ( ( a repeat ) ( scheduled ( cesarean section ) ) ) ( with ( ( ( an ( Apgar score ) ) ( of 4 ) ) ( at ( one minute ) ) ) ) ) ) ) ) , ) ( ( 5 ( ( ( ( at ( five minutes ) ) , ) and ) 7 ) ) ( at ( ten minutes ) ) ) ) . ) ) )

( ( The patient ) ( ( was ( born premature ) ) . ) )

23ecf99a-66c7-11e7-b137-f45c89b91419

entailment

He was responsive to commands and was trying to sit up.

He was able to react when spoken to

(ROOT (S (NP (PRP He)) (VP (VP (VBD was) (ADJP (JJ responsive) (PP (TO to) (NP (NNS commands))))) (CC and) (VP (VBD was) (VP (VBG trying) (S (VP (TO to) (VP (VB sit) (PRT (RP up)))))))) (. .)))

(ROOT (S (NP (PRP He)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB react) (SBAR (WHADVP (WRB when)) (S (VP (VBN spoken) (PP (TO to))))))))))))

( He ( ( ( ( was ( responsive ( to commands ) ) ) and ) ( was ( trying ( to ( sit up ) ) ) ) ) . ) )

( He ( was ( able ( to ( react ( when ( spoken to ) ) ) ) ) ) )

23ecfb3e-66c7-11e7-95b0-f45c89b91419

contradiction

He was responsive to commands and was trying to sit up.

He was comatose

(ROOT (S (NP (PRP He)) (VP (VP (VBD was) (ADJP (JJ responsive) (PP (TO to) (NP (NNS commands))))) (CC and) (VP (VBD was) (VP (VBG trying) (S (VP (TO to) (VP (VB sit) (PRT (RP up)))))))) (. .)))

(ROOT (S (NP (PRP He)) (VP (VBD was) (ADJP (JJ comatose)))))

( He ( ( ( ( was ( responsive ( to commands ) ) ) and ) ( was ( trying ( to ( sit up ) ) ) ) ) . ) )

( He ( was comatose ) )

23ecfce2-66c7-11e7-a162-f45c89b91419

neutral

He was responsive to commands and was trying to sit up.

He has a history of drug overdose

(ROOT (S (NP (PRP He)) (VP (VP (VBD was) (ADJP (JJ responsive) (PP (TO to) (NP (NNS commands))))) (CC and) (VP (VBD was) (VP (VBG trying) (S (VP (TO to) (VP (VB sit) (PRT (RP up)))))))) (. .)))

(ROOT (S (NP (PRP He)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN drug) (NN overdose)))))))

( He ( ( ( ( was ( responsive ( to commands ) ) ) and ) ( was ( trying ( to ( sit up ) ) ) ) ) . ) )

( He ( has ( ( a history ) ( of ( drug overdose ) ) ) ) )

23ecfec0-66c7-11e7-92f7-f45c89b91419

entailment

She started taking ibuprofen for it at [**First Name8 (NamePattern2) **] [**Last Name (un) 5416**] dose.

The patient is taking pain medicine.

(ROOT (S (NP (PRP She)) (VP (VBD started) (VP (VBG taking) (NP (NN ibuprofen)) (PP (IN for) (NP (PRP it))) (PP (IN at) (FRAG (-LRB- -LSB-) (NP (SYM **) (LS First) (NP (NP (NN Name8)) (PRN (-LRB- -LRB-) (NP (NN NamePattern2)) (-RRB- -RRB-))) (X (SYM **)) (-RRB- -RSB-) (-LRB- -LSB-) (SYM **) (NP (NP (JJ Last) (NN Name)) (PRN (-LRB- -LRB-) (NP (NN un)) (-RRB- -RRB-))) (CD 5416) (X (SYM **)) (-RRB- -RSB-) (NN dose)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (VP (VBG taking) (NP (NN pain) (NN medicine)))) (. .)))

( She ( ( started ( ( ( taking ibuprofen ) ( for it ) ) ( at ( -LSB- ( ** ( First ( ( Name8 ( -LRB- ( NamePattern2 -RRB- ) ) ) ( ** ( -RSB- ( -LSB- ( ** ( ( ( Last Name ) ( -LRB- ( un -RRB- ) ) ) ( 5416 ( ** ( -RSB- dose ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( is ( taking ( pain medicine ) ) ) . ) )

23ed00a2-66c7-11e7-ad5c-f45c89b91419

contradiction

She started taking ibuprofen for it at [**First Name8 (NamePattern2) **] [**Last Name (un) 5416**] dose.

The patient is not in pain.

(ROOT (S (NP (PRP She)) (VP (VBD started) (VP (VBG taking) (NP (NN ibuprofen)) (PP (IN for) (NP (PRP it))) (PP (IN at) (FRAG (-LRB- -LSB-) (NP (SYM **) (LS First) (NP (NP (NN Name8)) (PRN (-LRB- -LRB-) (NP (NN NamePattern2)) (-RRB- -RRB-))) (X (SYM **)) (-RRB- -RSB-) (-LRB- -LSB-) (SYM **) (NP (NP (JJ Last) (NN Name)) (PRN (-LRB- -LRB-) (NP (NN un)) (-RRB- -RRB-))) (CD 5416) (X (SYM **)) (-RRB- -RSB-) (NN dose)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (RB not) (PP (IN in) (NP (NN pain)))) (. .)))

( She ( ( started ( ( ( taking ibuprofen ) ( for it ) ) ( at ( -LSB- ( ** ( First ( ( Name8 ( -LRB- ( NamePattern2 -RRB- ) ) ) ( ** ( -RSB- ( -LSB- ( ** ( ( ( Last Name ) ( -LRB- ( un -RRB- ) ) ) ( 5416 ( ** ( -RSB- dose ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( ( is not ) ( in pain ) ) . ) )

23ed0302-66c7-11e7-80c0-f45c89b91419

neutral

She started taking ibuprofen for it at [**First Name8 (NamePattern2) **] [**Last Name (un) 5416**] dose.

The patient has a musculoskeletal injury.

(ROOT (S (NP (PRP She)) (VP (VBD started) (VP (VBG taking) (NP (NN ibuprofen)) (PP (IN for) (NP (PRP it))) (PP (IN at) (FRAG (-LRB- -LSB-) (NP (SYM **) (LS First) (NP (NP (NN Name8)) (PRN (-LRB- -LRB-) (NP (NN NamePattern2)) (-RRB- -RRB-))) (X (SYM **)) (-RRB- -RSB-) (-LRB- -LSB-) (SYM **) (NP (NP (JJ Last) (NN Name)) (PRN (-LRB- -LRB-) (NP (NN un)) (-RRB- -RRB-))) (CD 5416) (X (SYM **)) (-RRB- -RSB-) (NN dose)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ musculoskeletal) (NN injury))) (. .)))

( She ( ( started ( ( ( taking ibuprofen ) ( for it ) ) ( at ( -LSB- ( ** ( First ( ( Name8 ( -LRB- ( NamePattern2 -RRB- ) ) ) ( ** ( -RSB- ( -LSB- ( ** ( ( ( Last Name ) ( -LRB- ( un -RRB- ) ) ) ( 5416 ( ** ( -RSB- dose ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( a ( musculoskeletal injury ) ) ) . ) )

23ed0530-66c7-11e7-a894-f45c89b91419

entailment

In the ED, was noted to have initial FSBS 142 at 17:55, then drifted to 74, at 18:30, and started on D10 drip at 100/hr, since then sugars have been 83-143-11 every 40 minutes.

The patient had falling blood sguars.

(ROOT (S (PP (IN In) (NP (DT the) (NNP ED))) (, ,) (VP (VBD was) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (NP (JJ initial) (NN FSBS) (CD 142)) (PP (IN at) (NP (CD 17:55)))))))) (, ,) (S (ADVP (RB then)) (VP (VBD drifted) (PP (TO to) (NP (CD 74))) (, ,) (PP (IN at) (NP (CD 18:30))) (, ,) (CC and) (VP (VBD started) (PP (IN on) (NP (NP (NN D10) (NN drip)) (PP (IN at) (NP (CD 100/hr))))) (, ,) (SBAR (IN since) (S (NP (NP (RB then)) (NNS sugars)) (VP (VBP have) (VP (VBN been) (NP (CD 83-143-11)) (NP (DT every) (CD 40) (NNS minutes))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (VP (VBG falling) (NP (NN blood) (NNS sguars)))) (. .)))

( ( In ( the ED ) ) ( , ( ( ( ( was ( noted ( to ( ( have ( initial ( FSBS 142 ) ) ) ( at 17:55 ) ) ) ) ) , ) ( then ( ( ( ( ( ( drifted ( to 74 ) ) , ) ( at 18:30 ) ) , ) and ) ( ( ( started ( on ( ( D10 drip ) ( at 100/hr ) ) ) ) , ) ( since ( ( then sugars ) ( have ( ( been 83-143-11 ) ( every ( 40 minutes ) ) ) ) ) ) ) ) ) ) . ) ) )

( ( The patient ) ( ( had ( falling ( blood sguars ) ) ) . ) )

23ed0852-66c7-11e7-8806-f45c89b91419

contradiction

In the ED, was noted to have initial FSBS 142 at 17:55, then drifted to 74, at 18:30, and started on D10 drip at 100/hr, since then sugars have been 83-143-11 every 40 minutes.

The patient has normal blood glucose values.

(ROOT (S (PP (IN In) (NP (DT the) (NNP ED))) (, ,) (VP (VBD was) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (NP (JJ initial) (NN FSBS) (CD 142)) (PP (IN at) (NP (CD 17:55)))))))) (, ,) (S (ADVP (RB then)) (VP (VBD drifted) (PP (TO to) (NP (CD 74))) (, ,) (PP (IN at) (NP (CD 18:30))) (, ,) (CC and) (VP (VBD started) (PP (IN on) (NP (NP (NN D10) (NN drip)) (PP (IN at) (NP (CD 100/hr))))) (, ,) (SBAR (IN since) (S (NP (NP (RB then)) (NNS sugars)) (VP (VBP have) (VP (VBN been) (NP (CD 83-143-11)) (NP (DT every) (CD 40) (NNS minutes))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ normal) (NN blood) (NN glucose) (NNS values))) (. .)))

( ( In ( the ED ) ) ( , ( ( ( ( was ( noted ( to ( ( have ( initial ( FSBS 142 ) ) ) ( at 17:55 ) ) ) ) ) , ) ( then ( ( ( ( ( ( drifted ( to 74 ) ) , ) ( at 18:30 ) ) , ) and ) ( ( ( started ( on ( ( D10 drip ) ( at 100/hr ) ) ) ) , ) ( since ( ( then sugars ) ( have ( ( been 83-143-11 ) ( every ( 40 minutes ) ) ) ) ) ) ) ) ) ) . ) ) )

( ( The patient ) ( ( has ( normal ( blood ( glucose values ) ) ) ) . ) )

23ed0a8c-66c7-11e7-b043-f45c89b91419

neutral

In the ED, was noted to have initial FSBS 142 at 17:55, then drifted to 74, at 18:30, and started on D10 drip at 100/hr, since then sugars have been 83-143-11 every 40 minutes.

The patient had insulin overdose.

(ROOT (S (PP (IN In) (NP (DT the) (NNP ED))) (, ,) (VP (VBD was) (VP (VBN noted) (S (VP (TO to) (VP (VB have) (NP (JJ initial) (NN FSBS) (CD 142)) (PP (IN at) (NP (CD 17:55)))))))) (, ,) (S (ADVP (RB then)) (VP (VBD drifted) (PP (TO to) (NP (CD 74))) (, ,) (PP (IN at) (NP (CD 18:30))) (, ,) (CC and) (VP (VBD started) (PP (IN on) (NP (NP (NN D10) (NN drip)) (PP (IN at) (NP (CD 100/hr))))) (, ,) (SBAR (IN since) (S (NP (NP (RB then)) (NNS sugars)) (VP (VBP have) (VP (VBN been) (NP (CD 83-143-11)) (NP (DT every) (CD 40) (NNS minutes))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NN insulin) (NN overdose))) (. .)))

( ( In ( the ED ) ) ( , ( ( ( ( was ( noted ( to ( ( have ( initial ( FSBS 142 ) ) ) ( at 17:55 ) ) ) ) ) , ) ( then ( ( ( ( ( ( drifted ( to 74 ) ) , ) ( at 18:30 ) ) , ) and ) ( ( ( started ( on ( ( D10 drip ) ( at 100/hr ) ) ) ) , ) ( since ( ( then sugars ) ( have ( ( been 83-143-11 ) ( every ( 40 minutes ) ) ) ) ) ) ) ) ) ) . ) ) )

( ( The patient ) ( ( had ( insulin overdose ) ) . ) )

23ed0c62-66c7-11e7-9327-f45c89b91419

entailment

Hemi-sternotomy and lead extraction on [**3090-11-5**].

patient has history of lead extraction

(ROOT (NP (NP (NP (NP (ADJP (JJ Hemi-sternotomy))) (CC and) (NP (JJ lead) (NN extraction))) (PP (IN on) (PRN (-LRB- -LSB-) (NP (SYM **) (CD 3090-11-5) (X (SYM **)) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (NP (NN history)) (PP (IN of) (NP (NN lead) (NN extraction)))))))

( ( ( ( Hemi-sternotomy and ) ( lead extraction ) ) ( on ( -LSB- ( ** ( ( 3090-11-5 ** ) -RSB- ) ) ) ) ) . )

( patient ( has ( history ( of ( lead extraction ) ) ) ) )

23ed0dfa-66c7-11e7-af12-f45c89b91419

contradiction

Hemi-sternotomy and lead extraction on [**3090-11-5**].

patient has no cardiac history

(ROOT (NP (NP (NP (NP (ADJP (JJ Hemi-sternotomy))) (CC and) (NP (JJ lead) (NN extraction))) (PP (IN on) (PRN (-LRB- -LSB-) (NP (SYM **) (CD 3090-11-5) (X (SYM **)) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (DT no) (JJ cardiac) (NN history)))))

( ( ( ( Hemi-sternotomy and ) ( lead extraction ) ) ( on ( -LSB- ( ** ( ( 3090-11-5 ** ) -RSB- ) ) ) ) ) . )

( patient ( has ( no ( cardiac history ) ) ) )

23ed0f9e-66c7-11e7-9adb-f45c89b91419

neutral

Hemi-sternotomy and lead extraction on [**3090-11-5**].

clinical team is attempting to obtain MRI

(ROOT (NP (NP (NP (NP (ADJP (JJ Hemi-sternotomy))) (CC and) (NP (JJ lead) (NN extraction))) (PP (IN on) (PRN (-LRB- -LSB-) (NP (SYM **) (CD 3090-11-5) (X (SYM **)) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (JJ clinical) (NN team)) (VP (VBZ is) (VP (VBG attempting) (S (VP (TO to) (VP (VB obtain) (NP (NNP MRI)))))))))

( ( ( ( Hemi-sternotomy and ) ( lead extraction ) ) ( on ( -LSB- ( ** ( ( 3090-11-5 ** ) -RSB- ) ) ) ) ) . )

( ( clinical team ) ( is ( attempting ( to ( obtain MRI ) ) ) ) )

23ed1162-66c7-11e7-b2f1-f45c89b91419

entailment

Recurrence noted on brain biopsy by [**2663-5-19**].

Abnormal brain biopsy

(ROOT (S (NP (NN Recurrence)) (VP (VBD noted) (PP (IN on) (NP (NN brain) (NN biopsy))) (PP (IN by) (NP (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2663-5-19)) (X (SYM **))) (-RRB- -RSB-))))) (. .)))

(ROOT (NP (JJ Abnormal) (NN brain) (NN biopsy)))

( Recurrence ( ( ( noted ( on ( brain biopsy ) ) ) ( by ( -LSB- ( ( ** ( 2663-5-19 ** ) ) -RSB- ) ) ) ) . ) )

( Abnormal ( brain biopsy ) )

23ed1452-66c7-11e7-841b-f45c89b91419

contradiction

Recurrence noted on brain biopsy by [**2663-5-19**].

Brain biopsy is normal

(ROOT (S (NP (NN Recurrence)) (VP (VBD noted) (PP (IN on) (NP (NN brain) (NN biopsy))) (PP (IN by) (NP (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2663-5-19)) (X (SYM **))) (-RRB- -RSB-))))) (. .)))

(ROOT (S (NP (NN Brain) (NN biopsy)) (VP (VBZ is) (ADJP (JJ normal)))))

( Recurrence ( ( ( noted ( on ( brain biopsy ) ) ) ( by ( -LSB- ( ( ** ( 2663-5-19 ** ) ) -RSB- ) ) ) ) . ) )

( ( Brain biopsy ) ( is normal ) )

23ed1964-66c7-11e7-aaa6-f45c89b91419

neutral

Recurrence noted on brain biopsy by [**2663-5-19**].

Intracranial neoplasm

(ROOT (S (NP (NN Recurrence)) (VP (VBD noted) (PP (IN on) (NP (NN brain) (NN biopsy))) (PP (IN by) (NP (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2663-5-19)) (X (SYM **))) (-RRB- -RSB-))))) (. .)))

(ROOT (NP (JJ Intracranial) (NN neoplasm)))

( Recurrence ( ( ( noted ( on ( brain biopsy ) ) ) ( by ( -LSB- ( ( ** ( 2663-5-19 ** ) ) -RSB- ) ) ) ) . ) )

( Intracranial neoplasm )

23ed1e6e-66c7-11e7-a3a2-f45c89b91419

entailment

She was started on a bicarbonate drip and given charcoal for a presumed TCA overdose.

She was treated for possible overdose on tricyclic antidepressants

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VP (VBN started) (PP (IN on) (NP (DT a) (NN bicarbonate) (NN drip)))) (CC and) (VP (VBN given) (NP (NP (NN charcoal)) (PP (IN for) (NP (DT a) (JJ presumed) (NN TCA) (NN overdose))))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN treated) (PP (IN for) (NP (JJ possible) (NN overdose))) (PP (IN on) (NP (JJ tricyclic) (NNS antidepressants)))))))

( She ( ( was ( ( ( started ( on ( a ( bicarbonate drip ) ) ) ) and ) ( given ( charcoal ( for ( a ( presumed ( TCA overdose ) ) ) ) ) ) ) ) . ) )

( She ( was ( ( treated ( for ( possible overdose ) ) ) ( on ( tricyclic antidepressants ) ) ) ) )

23ed2652-66c7-11e7-b64f-f45c89b91419

contradiction

She was started on a bicarbonate drip and given charcoal for a presumed TCA overdose.

No indication of drug overdose

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VP (VBN started) (PP (IN on) (NP (DT a) (NN bicarbonate) (NN drip)))) (CC and) (VP (VBN given) (NP (NP (NN charcoal)) (PP (IN for) (NP (DT a) (JJ presumed) (NN TCA) (NN overdose))))))) (. .)))

(ROOT (NP (NP (DT No) (NN indication)) (PP (IN of) (NP (NN drug) (NN overdose)))))

( She ( ( was ( ( ( started ( on ( a ( bicarbonate drip ) ) ) ) and ) ( given ( charcoal ( for ( a ( presumed ( TCA overdose ) ) ) ) ) ) ) ) . ) )

( ( No indication ) ( of ( drug overdose ) ) )

23ed2a58-66c7-11e7-bcc4-f45c89b91419

neutral

She was started on a bicarbonate drip and given charcoal for a presumed TCA overdose.

She has major depression

(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VP (VBN started) (PP (IN on) (NP (DT a) (NN bicarbonate) (NN drip)))) (CC and) (VP (VBN given) (NP (NP (NN charcoal)) (PP (IN for) (NP (DT a) (JJ presumed) (NN TCA) (NN overdose))))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (JJ major) (NN depression)))))

( She ( ( was ( ( ( started ( on ( a ( bicarbonate drip ) ) ) ) and ) ( given ( charcoal ( for ( a ( presumed ( TCA overdose ) ) ) ) ) ) ) ) . ) )

( She ( has ( major depression ) ) )

23ed2f94-66c7-11e7-83f5-f45c89b91419

entailment

On arrival to the [**Name (NI) **], pt's VS: T 98.7, HR 128, BP 111/55, RR 20, Sa02 100% on 2L.

The patient’s heart rate is high

(ROOT (FRAG (PP (IN On) (NP (NP (NN arrival)) (PP (TO to) (NP (DT the) (SBAR (-LRB- -LSB-) (SYM **) (S (VP (VB Name) (PRN (-LRB- -LRB-) (NP (NN NI)) (-RRB- -RRB-)) (X (SYM **)) (-RRB- -RSB-))) (, ,) (NP (NP (NP (NN pt) (POS 's)) (NNP VS)) (: :) (NP (NP (NN T) (CD 98.7)) (, ,) (NP (NN HR) (CD 128)) (, ,) (NP (NP (NNP BP)) (NP (CD 111/55))) (, ,) (NP (NN RR) (CD 20)) (, ,) (NP (NP (NP (NN Sa02)) (NP (CD 100) (NN %))) (PP (IN on) (NP (NN 2L))))))))))) (. .)))

(ROOT (S (NP (NP (DT The) (NN patient) (POS 's)) (NN heart) (NN rate)) (VP (VBZ is) (ADJP (JJ high)))))

( ( On ( arrival ( to ( the ( -LSB- ( ** ( ( ( ( ( Name ( -LRB- ( NI -RRB- ) ) ) ** ) -RSB- ) , ) ( ( ( ( pt 's ) VS ) : ) ( ( ( ( ( ( ( ( ( T 98.7 ) , ) ( HR 128 ) ) , ) ( BP 111/55 ) ) , ) ( RR 20 ) ) , ) ( ( Sa02 ( 100 % ) ) ( on 2L ) ) ) ) ) ) ) ) ) ) ) . )

( ( ( The ( patient 's ) ) ( heart rate ) ) ( is high ) )

23ed3ab6-66c7-11e7-b235-f45c89b91419

contradiction

On arrival to the [**Name (NI) **], pt's VS: T 98.7, HR 128, BP 111/55, RR 20, Sa02 100% on 2L.

The patient is hypertensive

(ROOT (FRAG (PP (IN On) (NP (NP (NN arrival)) (PP (TO to) (NP (DT the) (SBAR (-LRB- -LSB-) (SYM **) (S (VP (VB Name) (PRN (-LRB- -LRB-) (NP (NN NI)) (-RRB- -RRB-)) (X (SYM **)) (-RRB- -RSB-))) (, ,) (NP (NP (NP (NN pt) (POS 's)) (NNP VS)) (: :) (NP (NP (NN T) (CD 98.7)) (, ,) (NP (NN HR) (CD 128)) (, ,) (NP (NP (NNP BP)) (NP (CD 111/55))) (, ,) (NP (NN RR) (CD 20)) (, ,) (NP (NP (NP (NN Sa02)) (NP (CD 100) (NN %))) (PP (IN on) (NP (NN 2L))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (ADJP (JJ hypertensive)))))

( ( On ( arrival ( to ( the ( -LSB- ( ** ( ( ( ( ( Name ( -LRB- ( NI -RRB- ) ) ) ** ) -RSB- ) , ) ( ( ( ( pt 's ) VS ) : ) ( ( ( ( ( ( ( ( ( T 98.7 ) , ) ( HR 128 ) ) , ) ( BP 111/55 ) ) , ) ( RR 20 ) ) , ) ( ( Sa02 ( 100 % ) ) ( on 2L ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( is hypertensive ) )

23ed424a-66c7-11e7-8ea0-f45c89b91419

neutral

On arrival to the [**Name (NI) **], pt's VS: T 98.7, HR 128, BP 111/55, RR 20, Sa02 100% on 2L.

The patient has a history of COPD

(ROOT (FRAG (PP (IN On) (NP (NP (NN arrival)) (PP (TO to) (NP (DT the) (SBAR (-LRB- -LSB-) (SYM **) (S (VP (VB Name) (PRN (-LRB- -LRB-) (NP (NN NI)) (-RRB- -RRB-)) (X (SYM **)) (-RRB- -RSB-))) (, ,) (NP (NP (NP (NN pt) (POS 's)) (NNP VS)) (: :) (NP (NP (NN T) (CD 98.7)) (, ,) (NP (NN HR) (CD 128)) (, ,) (NP (NP (NNP BP)) (NP (CD 111/55))) (, ,) (NP (NN RR) (CD 20)) (, ,) (NP (NP (NP (NN Sa02)) (NP (CD 100) (NN %))) (PP (IN on) (NP (NN 2L))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNP COPD)))))))

( ( On ( arrival ( to ( the ( -LSB- ( ** ( ( ( ( ( Name ( -LRB- ( NI -RRB- ) ) ) ** ) -RSB- ) , ) ( ( ( ( pt 's ) VS ) : ) ( ( ( ( ( ( ( ( ( T 98.7 ) , ) ( HR 128 ) ) , ) ( BP 111/55 ) ) , ) ( RR 20 ) ) , ) ( ( Sa02 ( 100 % ) ) ( on 2L ) ) ) ) ) ) ) ) ) ) ) . )

( ( The patient ) ( has ( ( a history ) ( of COPD ) ) ) )

23ed484c-66c7-11e7-b5e6-f45c89b91419

entailment

Her initial evaluation was by Dr. [**Last Name (STitle) 8265**] [**Name (STitle) 8266**] and at that time patient was upper quadrant pain, no nausea, vomiting, fever, chills or fatigue, hepatosplenomegaly, jaundice or encephalopathy.

She was previously evaluated for abdominal pain

(ROOT (S (NP (PRP$ Her) (JJ initial) (NN evaluation)) (VP (VBD was) (PP (IN by) (NP (NNP Dr.))) (INTJ (-LRB- -LSB-) (QP (S (SYM **) (S (NP (NP (JJ Last) (NN Name)) (PRN (-LRB- -LRB-) (NP (NN STitle)) (-RRB- -RRB-))) (VP (CD 8265) (SBAR (X (SYM **)) (S (-RRB- -RSB-) (S (-LRB- -LSB-) (VP (VP (SYM **) (VB Name) (PRN (-LRB- -LRB-) (NP (NN STitle)) (-RRB- -RRB-)) (ADVP (CD 8266) (X (SYM **))) (VP (-RRB- -RSB-))) (CC and) (SBAR (S (PP (IN at) (NP (DT that) (NN time) (NN patient))) (VP (VBD was) (NP (JJ upper) (JJ quadrant) (NN pain)) (, ,) (NP (NP (DT no) (NN nausea)) (, ,) (NP (VBG vomiting) (, ,) (NN fever) (, ,) (NNS chills) (CC or) (NN fatigue)) (, ,) (ADVP (RB hepatosplenomegaly)) (, ,) (NP (NP (NN jaundice)) (CC or) (NP (NN encephalopathy))))))))))))))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBD was) (ADVP (RB previously)) (VP (VBN evaluated) (PP (IN for) (NP (JJ abdominal) (NN pain)))))))

( ( Her ( initial evaluation ) ) ( ( ( was ( by Dr. ) ) ( -LSB- ( ** ( ( ( Last Name ) ( -LRB- ( STitle -RRB- ) ) ) ( 8265 ( ** ( -RSB- ( -LSB- ( ( ( ** ( ( ( Name ( -LRB- ( STitle -RRB- ) ) ) ( 8266 ** ) ) -RSB- ) ) and ) ( ( at ( that ( time patient ) ) ) ( ( ( was ( upper ( quadrant pain ) ) ) , ) ( ( ( ( ( ( ( no nausea ) , ) ( vomiting ( , ( fever ( , ( ( chills or ) fatigue ) ) ) ) ) ) , ) hepatosplenomegaly ) , ) ( ( jaundice or ) encephalopathy ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( She ( ( was previously ) ( evaluated ( for ( abdominal pain ) ) ) ) )

23ed531e-66c7-11e7-ada9-f45c89b91419

contradiction

Her initial evaluation was by Dr. [**Last Name (STitle) 8265**] [**Name (STitle) 8266**] and at that time patient was upper quadrant pain, no nausea, vomiting, fever, chills or fatigue, hepatosplenomegaly, jaundice or encephalopathy.

She has had no recent complaints of abdominal pain

(ROOT (S (NP (PRP$ Her) (JJ initial) (NN evaluation)) (VP (VBD was) (PP (IN by) (NP (NNP Dr.))) (INTJ (-LRB- -LSB-) (QP (S (SYM **) (S (NP (NP (JJ Last) (NN Name)) (PRN (-LRB- -LRB-) (NP (NN STitle)) (-RRB- -RRB-))) (VP (CD 8265) (SBAR (X (SYM **)) (S (-RRB- -RSB-) (S (-LRB- -LSB-) (VP (VP (SYM **) (VB Name) (PRN (-LRB- -LRB-) (NP (NN STitle)) (-RRB- -RRB-)) (ADVP (CD 8266) (X (SYM **))) (VP (-RRB- -RSB-))) (CC and) (SBAR (S (PP (IN at) (NP (DT that) (NN time) (NN patient))) (VP (VBD was) (NP (JJ upper) (JJ quadrant) (NN pain)) (, ,) (NP (NP (DT no) (NN nausea)) (, ,) (NP (VBG vomiting) (, ,) (NN fever) (, ,) (NNS chills) (CC or) (NN fatigue)) (, ,) (ADVP (RB hepatosplenomegaly)) (, ,) (NP (NP (NN jaundice)) (CC or) (NP (NN encephalopathy))))))))))))))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ has) (VP (VBN had) (NP (NP (DT no) (JJ recent) (NNS complaints)) (PP (IN of) (NP (JJ abdominal) (NN pain))))))))

( ( Her ( initial evaluation ) ) ( ( ( was ( by Dr. ) ) ( -LSB- ( ** ( ( ( Last Name ) ( -LRB- ( STitle -RRB- ) ) ) ( 8265 ( ** ( -RSB- ( -LSB- ( ( ( ** ( ( ( Name ( -LRB- ( STitle -RRB- ) ) ) ( 8266 ** ) ) -RSB- ) ) and ) ( ( at ( that ( time patient ) ) ) ( ( ( was ( upper ( quadrant pain ) ) ) , ) ( ( ( ( ( ( ( no nausea ) , ) ( vomiting ( , ( fever ( , ( ( chills or ) fatigue ) ) ) ) ) ) , ) hepatosplenomegaly ) , ) ( ( jaundice or ) encephalopathy ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( She ( has ( had ( ( no ( recent complaints ) ) ( of ( abdominal pain ) ) ) ) ) )

23ed62e8-66c7-11e7-bfe0-f45c89b91419

neutral

Her initial evaluation was by Dr. [**Last Name (STitle) 8265**] [**Name (STitle) 8266**] and at that time patient was upper quadrant pain, no nausea, vomiting, fever, chills or fatigue, hepatosplenomegaly, jaundice or encephalopathy.

She has a history of gall bladder disease

(ROOT (S (NP (PRP$ Her) (JJ initial) (NN evaluation)) (VP (VBD was) (PP (IN by) (NP (NNP Dr.))) (INTJ (-LRB- -LSB-) (QP (S (SYM **) (S (NP (NP (JJ Last) (NN Name)) (PRN (-LRB- -LRB-) (NP (NN STitle)) (-RRB- -RRB-))) (VP (CD 8265) (SBAR (X (SYM **)) (S (-RRB- -RSB-) (S (-LRB- -LSB-) (VP (VP (SYM **) (VB Name) (PRN (-LRB- -LRB-) (NP (NN STitle)) (-RRB- -RRB-)) (ADVP (CD 8266) (X (SYM **))) (VP (-RRB- -RSB-))) (CC and) (SBAR (S (PP (IN at) (NP (DT that) (NN time) (NN patient))) (VP (VBD was) (NP (JJ upper) (JJ quadrant) (NN pain)) (, ,) (NP (NP (DT no) (NN nausea)) (, ,) (NP (VBG vomiting) (, ,) (NN fever) (, ,) (NNS chills) (CC or) (NN fatigue)) (, ,) (ADVP (RB hepatosplenomegaly)) (, ,) (NP (NP (NN jaundice)) (CC or) (NP (NN encephalopathy))))))))))))))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN gall) (NN bladder) (NN disease)))))))

( ( Her ( initial evaluation ) ) ( ( ( was ( by Dr. ) ) ( -LSB- ( ** ( ( ( Last Name ) ( -LRB- ( STitle -RRB- ) ) ) ( 8265 ( ** ( -RSB- ( -LSB- ( ( ( ** ( ( ( Name ( -LRB- ( STitle -RRB- ) ) ) ( 8266 ** ) ) -RSB- ) ) and ) ( ( at ( that ( time patient ) ) ) ( ( ( was ( upper ( quadrant pain ) ) ) , ) ( ( ( ( ( ( ( no nausea ) , ) ( vomiting ( , ( fever ( , ( ( chills or ) fatigue ) ) ) ) ) ) , ) hepatosplenomegaly ) , ) ( ( jaundice or ) encephalopathy ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( She ( has ( ( a history ) ( of ( gall ( bladder disease ) ) ) ) ) )

23ed6df8-66c7-11e7-a5cd-f45c89b91419

entailment

I indicated to him that he has had a symptomatic manifestation of a tumor which likely is malignant in its nature.

The patient has a tumor which is likely malignant.

(ROOT (S (NP (PRP I)) (VP (VBD indicated) (PP (TO to) (NP (PRP him))) (SBAR (IN that) (S (NP (PRP he)) (VP (VBZ has) (VP (VBD had) (NP (NP (DT a) (JJ symptomatic) (NN manifestation)) (PP (IN of) (NP (NP (DT a) (NN tumor)) (SBAR (WHNP (WDT which)) (S (ADVP (JJ likely)) (VP (VBZ is) (ADJP (JJ malignant) (PP (IN in) (NP (PRP$ its) (NN nature))))))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN tumor)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ likely) (JJ malignant))))))) (. .)))

( I ( ( ( indicated ( to him ) ) ( that ( he ( has ( had ( ( a ( symptomatic manifestation ) ) ( of ( ( a tumor ) ( which ( likely ( is ( malignant ( in ( its nature ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( ( a tumor ) ( which ( is ( likely malignant ) ) ) ) ) . ) )

23ed76c0-66c7-11e7-a544-f45c89b91419

contradiction

I indicated to him that he has had a symptomatic manifestation of a tumor which likely is malignant in its nature.

The patient has no tumor.

(ROOT (S (NP (PRP I)) (VP (VBD indicated) (PP (TO to) (NP (PRP him))) (SBAR (IN that) (S (NP (PRP he)) (VP (VBZ has) (VP (VBD had) (NP (NP (DT a) (JJ symptomatic) (NN manifestation)) (PP (IN of) (NP (NP (DT a) (NN tumor)) (SBAR (WHNP (WDT which)) (S (ADVP (JJ likely)) (VP (VBZ is) (ADJP (JJ malignant) (PP (IN in) (NP (PRP$ its) (NN nature))))))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT no) (NN tumor))) (. .)))

( I ( ( ( indicated ( to him ) ) ( that ( he ( has ( had ( ( a ( symptomatic manifestation ) ) ( of ( ( a tumor ) ( which ( likely ( is ( malignant ( in ( its nature ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( no tumor ) ) . ) )

23ed7b00-66c7-11e7-85da-f45c89b91419

neutral

I indicated to him that he has had a symptomatic manifestation of a tumor which likely is malignant in its nature.

The patient has lung cancer.

(ROOT (S (NP (PRP I)) (VP (VBD indicated) (PP (TO to) (NP (PRP him))) (SBAR (IN that) (S (NP (PRP he)) (VP (VBZ has) (VP (VBD had) (NP (NP (DT a) (JJ symptomatic) (NN manifestation)) (PP (IN of) (NP (NP (DT a) (NN tumor)) (SBAR (WHNP (WDT which)) (S (ADVP (JJ likely)) (VP (VBZ is) (ADJP (JJ malignant) (PP (IN in) (NP (PRP$ its) (NN nature))))))))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NN lung) (NN cancer))) (. .)))

( I ( ( ( indicated ( to him ) ) ( that ( he ( has ( had ( ( a ( symptomatic manifestation ) ) ( of ( ( a tumor ) ( which ( likely ( is ( malignant ( in ( its nature ) ) ) ) ) ) ) ) ) ) ) ) ) ) . ) )

( ( The patient ) ( ( has ( lung cancer ) ) . ) )

23ed7efe-66c7-11e7-bc88-f45c89b91419

entailment

53 year-old male with progressive multiple sclerosis and recent episode of urosepsis admitted from PCP's office with generalized weakness and tachycardia.

Patient has history of UTIs

(ROOT (NP (NP (NP (CD 53) (JJ year-old) (NN male)) (PP (IN with) (NP (NP (JJ progressive) (JJ multiple) (NN sclerosis)) (CC and) (NP (NP (JJ recent) (NN episode)) (PP (IN of) (NP (NP (NN urosepsis)) (VP (VBN admitted) (PP (IN from) (NP (NP (NN PCP) (POS 's)) (NN office))) (SBAR (IN with) (S (VP (VBN generalized) (NP (NP (NN weakness)) (CC and) (NP (NN tachycardia))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NP (NN history)) (PP (IN of) (NP (NNS UTIs)))))))

( ( ( 53 ( year-old male ) ) ( with ( ( ( progressive ( multiple sclerosis ) ) and ) ( ( recent episode ) ( of ( urosepsis ( ( admitted ( from ( ( PCP 's ) office ) ) ) ( with ( generalized ( ( weakness and ) tachycardia ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( history ( of UTIs ) ) ) )

23ed8282-66c7-11e7-866c-f45c89b91419

contradiction

53 year-old male with progressive multiple sclerosis and recent episode of urosepsis admitted from PCP's office with generalized weakness and tachycardia.

Patient has a normal neurologic exam

(ROOT (NP (NP (NP (CD 53) (JJ year-old) (NN male)) (PP (IN with) (NP (NP (JJ progressive) (JJ multiple) (NN sclerosis)) (CC and) (NP (NP (JJ recent) (NN episode)) (PP (IN of) (NP (NP (NN urosepsis)) (VP (VBN admitted) (PP (IN from) (NP (NP (NN PCP) (POS 's)) (NN office))) (SBAR (IN with) (S (VP (VBN generalized) (NP (NP (NN weakness)) (CC and) (NP (NN tachycardia))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (JJ normal) (JJ neurologic) (NN exam)))))

( ( ( 53 ( year-old male ) ) ( with ( ( ( progressive ( multiple sclerosis ) ) and ) ( ( recent episode ) ( of ( urosepsis ( ( admitted ( from ( ( PCP 's ) office ) ) ) ( with ( generalized ( ( weakness and ) tachycardia ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( a ( normal ( neurologic exam ) ) ) ) )

23ed986c-66c7-11e7-9e9e-f45c89b91419

neutral

53 year-old male with progressive multiple sclerosis and recent episode of urosepsis admitted from PCP's office with generalized weakness and tachycardia.

Patient has a neurological disorder

(ROOT (NP (NP (NP (CD 53) (JJ year-old) (NN male)) (PP (IN with) (NP (NP (JJ progressive) (JJ multiple) (NN sclerosis)) (CC and) (NP (NP (JJ recent) (NN episode)) (PP (IN of) (NP (NP (NN urosepsis)) (VP (VBN admitted) (PP (IN from) (NP (NP (NN PCP) (POS 's)) (NN office))) (SBAR (IN with) (S (VP (VBN generalized) (NP (NP (NN weakness)) (CC and) (NP (NN tachycardia))))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (DT a) (JJ neurological) (NN disorder)))))

( ( ( 53 ( year-old male ) ) ( with ( ( ( progressive ( multiple sclerosis ) ) and ) ( ( recent episode ) ( of ( urosepsis ( ( admitted ( from ( ( PCP 's ) office ) ) ) ( with ( generalized ( ( weakness and ) tachycardia ) ) ) ) ) ) ) ) ) ) . )

( Patient ( has ( a ( neurological disorder ) ) ) )

23ed9d3a-66c7-11e7-83f8-f45c89b91419

entailment

SVT v. atrial flutter v. atrial fibrillation seen on multiple EKGs.

The patient has a tachyarythmia.

(ROOT (NP (NP (NP (NNP SVT)) (PP (CC v.) (NP (NP (JJ atrial) (NN flutter)) (PP (CC v.) (NP (NP (JJ atrial) (NN fibrillation)) (VP (VBN seen) (PP (IN on) (NP (JJ multiple) (NNS EKGs))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (NN tachyarythmia))) (. .)))

( ( SVT ( v. ( ( atrial flutter ) ( v. ( ( atrial fibrillation ) ( seen ( on ( multiple EKGs ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( a tachyarythmia ) ) . ) )

23eda082-66c7-11e7-ad33-f45c89b91419

contradiction

SVT v. atrial flutter v. atrial fibrillation seen on multiple EKGs.

The patients EKG are all with regular rate and rhythm.

(ROOT (NP (NP (NP (NNP SVT)) (PP (CC v.) (NP (NP (JJ atrial) (NN flutter)) (PP (CC v.) (NP (NP (JJ atrial) (NN fibrillation)) (VP (VBN seen) (PP (IN on) (NP (JJ multiple) (NNS EKGs))))))))) (. .)))

(ROOT (S (NP (DT The) (NNS patients)) (NP (NNP EKG)) (VP (VBP are) (ADVP (DT all)) (PP (IN with) (NP (NP (JJ regular) (NN rate)) (CC and) (NP (NN rhythm))))) (. .)))

( ( SVT ( v. ( ( atrial flutter ) ( v. ( ( atrial fibrillation ) ( seen ( on ( multiple EKGs ) ) ) ) ) ) ) ) . )

( ( The patients ) ( EKG ( ( ( are all ) ( with ( ( ( regular rate ) and ) rhythm ) ) ) . ) ) )

23eda438-66c7-11e7-8775-f45c89b91419

neutral

SVT v. atrial flutter v. atrial fibrillation seen on multiple EKGs.

The patient has congestive heart failure.

(ROOT (NP (NP (NP (NNP SVT)) (PP (CC v.) (NP (NP (JJ atrial) (NN flutter)) (PP (CC v.) (NP (NP (JJ atrial) (NN fibrillation)) (VP (VBN seen) (PP (IN on) (NP (JJ multiple) (NNS EKGs))))))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (JJ congestive) (NN heart) (NN failure))) (. .)))

( ( SVT ( v. ( ( atrial flutter ) ( v. ( ( atrial fibrillation ) ( seen ( on ( multiple EKGs ) ) ) ) ) ) ) ) . )

( ( The patient ) ( ( has ( congestive ( heart failure ) ) ) . ) )

23eda86e-66c7-11e7-b606-f45c89b91419

entailment

Cardiac catheterization showed CO 4.09, CI 1.95, PCWP 21, RA 12, PA 51/22 LMCA normal LAD: midsegment 80% lesion with modest calcium LCX: non-domninant vessel with mid-segment 90% lesion after OM1.

patient has coronary artery disease

(ROOT (S (S (NP (JJ Cardiac) (NN catheterization)) (VP (VBD showed) (NP (NP (NNP CO) (CD 4.09)) (, ,) (NP (NN CI) (CD 1.95)) (, ,) (NP (NN PCWP) (CD 21))) (, ,) (NP (NP (NN RA) (CD 12)) (, ,) (NP (NP (NN PA) (CD 51/22)) (NN LMCA) (JJ normal) (NN LAD))))) (: :) (NP (NP (NP (NN midsegment) (CD 80) (NN %) (NN lesion)) (PP (IN with) (NP (JJ modest) (NN calcium) (NN LCX)))) (: :) (NP (NP (NP (JJ non-domninant) (NN vessel)) (PP (IN with) (NP (NN mid-segment) (ADJP (CD 90) (NN %)) (NN lesion)))) (PP (IN after) (NP (NN OM1))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (JJ coronary) (NN artery) (NN disease)))))

( ( ( ( ( Cardiac catheterization ) ( ( ( showed ( ( ( ( ( CO 4.09 ) , ) ( CI 1.95 ) ) , ) ( PCWP 21 ) ) ) , ) ( ( ( RA 12 ) , ) ( ( PA 51/22 ) ( LMCA ( normal LAD ) ) ) ) ) ) : ) ( ( ( ( midsegment ( 80 ( % lesion ) ) ) ( with ( modest ( calcium LCX ) ) ) ) : ) ( ( ( non-domninant vessel ) ( with ( mid-segment ( ( 90 % ) lesion ) ) ) ) ( after OM1 ) ) ) ) . )

( patient ( has ( coronary ( artery disease ) ) ) )

23edaba4-66c7-11e7-a181-f45c89b91419

contradiction

Cardiac catheterization showed CO 4.09, CI 1.95, PCWP 21, RA 12, PA 51/22 LMCA normal LAD: midsegment 80% lesion with modest calcium LCX: non-domninant vessel with mid-segment 90% lesion after OM1.

patient has normal coronary arteries

(ROOT (S (S (NP (JJ Cardiac) (NN catheterization)) (VP (VBD showed) (NP (NP (NNP CO) (CD 4.09)) (, ,) (NP (NN CI) (CD 1.95)) (, ,) (NP (NN PCWP) (CD 21))) (, ,) (NP (NP (NN RA) (CD 12)) (, ,) (NP (NP (NN PA) (CD 51/22)) (NN LMCA) (JJ normal) (NN LAD))))) (: :) (NP (NP (NP (NN midsegment) (CD 80) (NN %) (NN lesion)) (PP (IN with) (NP (JJ modest) (NN calcium) (NN LCX)))) (: :) (NP (NP (NP (JJ non-domninant) (NN vessel)) (PP (IN with) (NP (NN mid-segment) (ADJP (CD 90) (NN %)) (NN lesion)))) (PP (IN after) (NP (NN OM1))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (JJ normal) (JJ coronary) (NNS arteries)))))

( ( ( ( ( Cardiac catheterization ) ( ( ( showed ( ( ( ( ( CO 4.09 ) , ) ( CI 1.95 ) ) , ) ( PCWP 21 ) ) ) , ) ( ( ( RA 12 ) , ) ( ( PA 51/22 ) ( LMCA ( normal LAD ) ) ) ) ) ) : ) ( ( ( ( midsegment ( 80 ( % lesion ) ) ) ( with ( modest ( calcium LCX ) ) ) ) : ) ( ( ( non-domninant vessel ) ( with ( mid-segment ( ( 90 % ) lesion ) ) ) ) ( after OM1 ) ) ) ) . )

( patient ( has ( normal ( coronary arteries ) ) ) )

23edb130-66c7-11e7-aed8-f45c89b91419

neutral

Cardiac catheterization showed CO 4.09, CI 1.95, PCWP 21, RA 12, PA 51/22 LMCA normal LAD: midsegment 80% lesion with modest calcium LCX: non-domninant vessel with mid-segment 90% lesion after OM1.

patient has diabetes

(ROOT (S (S (NP (JJ Cardiac) (NN catheterization)) (VP (VBD showed) (NP (NP (NNP CO) (CD 4.09)) (, ,) (NP (NN CI) (CD 1.95)) (, ,) (NP (NN PCWP) (CD 21))) (, ,) (NP (NP (NN RA) (CD 12)) (, ,) (NP (NP (NN PA) (CD 51/22)) (NN LMCA) (JJ normal) (NN LAD))))) (: :) (NP (NP (NP (NN midsegment) (CD 80) (NN %) (NN lesion)) (PP (IN with) (NP (JJ modest) (NN calcium) (NN LCX)))) (: :) (NP (NP (NP (JJ non-domninant) (NN vessel)) (PP (IN with) (NP (NN mid-segment) (ADJP (CD 90) (NN %)) (NN lesion)))) (PP (IN after) (NP (NN OM1))))) (. .)))

(ROOT (S (NP (NN patient)) (VP (VBZ has) (NP (NNS diabetes)))))

( ( ( ( ( Cardiac catheterization ) ( ( ( showed ( ( ( ( ( CO 4.09 ) , ) ( CI 1.95 ) ) , ) ( PCWP 21 ) ) ) , ) ( ( ( RA 12 ) , ) ( ( PA 51/22 ) ( LMCA ( normal LAD ) ) ) ) ) ) : ) ( ( ( ( midsegment ( 80 ( % lesion ) ) ) ( with ( modest ( calcium LCX ) ) ) ) : ) ( ( ( non-domninant vessel ) ( with ( mid-segment ( ( 90 % ) lesion ) ) ) ) ( after OM1 ) ) ) ) . )

( patient ( has diabetes ) )

23edba9a-66c7-11e7-b407-f45c89b91419

entailment

By [**3-23**], his bicarb had increased to 12 and his creatinine had improved to 1.4.

Patient has improving lab values

(ROOT (FRAG (PP (IN By) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (CD 3-23) (X (SYM **)) (-RRB- -RSB-)) (, ,) (SBAR (S (S (NP (PRP$ his) (NN bicarb)) (VP (VBD had) (VP (VBN increased) (PP (TO to) (NP (CD 12)))))) (CC and) (S (NP (PRP$ his) (NN creatinine)) (VP (VBD had) (VP (VBN improved) (PP (TO to) (NP (CD 1.4))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBG improving) (NP (NN lab) (NNS values))))))

( ( By ( -LSB- ( ( ( ** ( ( 3-23 ** ) -RSB- ) ) , ) ( ( ( ( his bicarb ) ( had ( increased ( to 12 ) ) ) ) and ) ( ( his creatinine ) ( had ( improved ( to 1.4 ) ) ) ) ) ) ) ) . )

( Patient ( has ( improving ( lab values ) ) ) )

23edbcd4-66c7-11e7-bf6a-f45c89b91419

contradiction

By [**3-23**], his bicarb had increased to 12 and his creatinine had improved to 1.4.

Patient has normal Cr

(ROOT (FRAG (PP (IN By) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (CD 3-23) (X (SYM **)) (-RRB- -RSB-)) (, ,) (SBAR (S (S (NP (PRP$ his) (NN bicarb)) (VP (VBD had) (VP (VBN increased) (PP (TO to) (NP (CD 12)))))) (CC and) (S (NP (PRP$ his) (NN creatinine)) (VP (VBD had) (VP (VBN improved) (PP (TO to) (NP (CD 1.4))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ normal) (NN Cr)))))

( ( By ( -LSB- ( ( ( ** ( ( 3-23 ** ) -RSB- ) ) , ) ( ( ( ( his bicarb ) ( had ( increased ( to 12 ) ) ) ) and ) ( ( his creatinine ) ( had ( improved ( to 1.4 ) ) ) ) ) ) ) ) . )

( Patient ( has ( normal Cr ) ) )

23edbebe-66c7-11e7-b986-f45c89b91419

neutral

By [**3-23**], his bicarb had increased to 12 and his creatinine had improved to 1.4.

Patient has CKD

(ROOT (FRAG (PP (IN By) (PRN (-LRB- -LSB-) (NP (NP (SYM **) (CD 3-23) (X (SYM **)) (-RRB- -RSB-)) (, ,) (SBAR (S (S (NP (PRP$ his) (NN bicarb)) (VP (VBD had) (VP (VBN increased) (PP (TO to) (NP (CD 12)))))) (CC and) (S (NP (PRP$ his) (NN creatinine)) (VP (VBD had) (VP (VBN improved) (PP (TO to) (NP (CD 1.4))))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (VP (VBN CKD)))))

( ( By ( -LSB- ( ( ( ** ( ( 3-23 ** ) -RSB- ) ) , ) ( ( ( ( his bicarb ) ( had ( increased ( to 12 ) ) ) ) and ) ( ( his creatinine ) ( had ( improved ( to 1.4 ) ) ) ) ) ) ) ) . )

( Patient ( has CKD ) )

23edc080-66c7-11e7-95c1-f45c89b91419

entailment

The leg from just above the knee was cool and mottled.

Patient has poor limb perfusion

(ROOT (NP (NP (NP (DT The) (NN leg)) (PP (IN from) (SBAR (RB just) (IN above) (S (NP (DT the) (NN knee)) (VP (VBD was) (ADJP (ADJP (JJ cool)) (CC and) (ADJP (JJ mottled)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ poor) (NN limb) (NN perfusion)))))

( ( ( The leg ) ( from ( just ( above ( ( the knee ) ( was ( ( cool and ) mottled ) ) ) ) ) ) ) . )

( Patient ( has ( poor ( limb perfusion ) ) ) )

23edc35a-66c7-11e7-a2c0-f45c89b91419

contradiction

The leg from just above the knee was cool and mottled.

Patient has normal leg perfusion

(ROOT (NP (NP (NP (DT The) (NN leg)) (PP (IN from) (SBAR (RB just) (IN above) (S (NP (DT the) (NN knee)) (VP (VBD was) (ADJP (ADJP (JJ cool)) (CC and) (ADJP (JJ mottled)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (JJ normal) (NN leg) (NN perfusion)))))

( ( ( The leg ) ( from ( just ( above ( ( the knee ) ( was ( ( cool and ) mottled ) ) ) ) ) ) ) . )

( Patient ( has ( normal ( leg perfusion ) ) ) )

23edc512-66c7-11e7-b466-f45c89b91419

neutral

The leg from just above the knee was cool and mottled.

Patient has PAD

(ROOT (NP (NP (NP (DT The) (NN leg)) (PP (IN from) (SBAR (RB just) (IN above) (S (NP (DT the) (NN knee)) (VP (VBD was) (ADJP (ADJP (JJ cool)) (CC and) (ADJP (JJ mottled)))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ has) (NP (NN PAD)))))

( ( ( The leg ) ( from ( just ( above ( ( the knee ) ( was ( ( cool and ) mottled ) ) ) ) ) ) ) . )

( Patient ( has PAD ) )

23edc6d4-66c7-11e7-b534-f45c89b91419

entailment

The test was discontinued and the patient's EKG changes initially largely resolved.

The patient had an abnormal EKG

(ROOT (S (NP (DT The) (NN test)) (VP (VBD was) (VP (VP (VBN discontinued)) (CC and) (SBAR (S (NP (NP (DT the) (NN patient) (POS 's)) (NNP EKG) (NNS changes)) (ADVP (RB initially)) (VP (ADVP (RB largely)) (VBN resolved)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (DT an) (JJ abnormal) (NNP EKG)))))

( ( The test ) ( ( was ( ( discontinued and ) ( ( ( the ( patient 's ) ) ( EKG changes ) ) ( initially ( largely resolved ) ) ) ) ) . ) )

( ( The patient ) ( had ( an ( abnormal EKG ) ) ) )

23edc9ec-66c7-11e7-a31c-f45c89b91419

contradiction

The test was discontinued and the patient's EKG changes initially largely resolved.

EKG changes resolved with cardioconversion

(ROOT (S (NP (DT The) (NN test)) (VP (VBD was) (VP (VP (VBN discontinued)) (CC and) (SBAR (S (NP (NP (DT the) (NN patient) (POS 's)) (NNP EKG) (NNS changes)) (ADVP (RB initially)) (VP (ADVP (RB largely)) (VBN resolved)))))) (. .)))

(ROOT (S (NP (NNP EKG)) (VP (VBZ changes) (VP (VBN resolved) (PP (IN with) (NP (NN cardioconversion)))))))

( ( The test ) ( ( was ( ( discontinued and ) ( ( ( the ( patient 's ) ) ( EKG changes ) ) ( initially ( largely resolved ) ) ) ) ) . ) )

( EKG ( changes ( resolved ( with cardioconversion ) ) ) )

23eddef8-66c7-11e7-98e2-f45c89b91419

neutral

The test was discontinued and the patient's EKG changes initially largely resolved.

The patient has a history of arrhythmia

(ROOT (S (NP (DT The) (NN test)) (VP (VBD was) (VP (VP (VBN discontinued)) (CC and) (SBAR (S (NP (NP (DT the) (NN patient) (POS 's)) (NNP EKG) (NNS changes)) (ADVP (RB initially)) (VP (ADVP (RB largely)) (VBN resolved)))))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN arrhythmia)))))))

( ( The test ) ( ( was ( ( discontinued and ) ( ( ( the ( patient 's ) ) ( EKG changes ) ) ( initially ( largely resolved ) ) ) ) ) . ) )

( ( The patient ) ( has ( ( a history ) ( of arrhythmia ) ) ) )

23ede678-66c7-11e7-b6e4-f45c89b91419

entailment

She does not answer ROS questions at this time.

She is a poor historian at this time

(ROOT (S (NP (PRP She)) (VP (VBZ does) (RB not) (VP (VB answer) (NP (NN ROS) (NNS questions)) (PP (IN at) (NP (DT this) (NN time))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ is) (NP (DT a) (JJ poor) (NN historian)) (PP (IN at) (NP (DT this) (NN time))))))

( She ( ( ( does not ) ( ( answer ( ROS questions ) ) ( at ( this time ) ) ) ) . ) )

( She ( ( is ( a ( poor historian ) ) ) ( at ( this time ) ) ) )

23edf262-66c7-11e7-b285-f45c89b91419

contradiction

She does not answer ROS questions at this time.

She provides a full history during interview

(ROOT (S (NP (PRP She)) (VP (VBZ does) (RB not) (VP (VB answer) (NP (NN ROS) (NNS questions)) (PP (IN at) (NP (DT this) (NN time))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ provides) (NP (DT a) (JJ full) (NN history)) (PP (IN during) (NP (NN interview))))))

( She ( ( ( does not ) ( ( answer ( ROS questions ) ) ( at ( this time ) ) ) ) . ) )

( She ( ( provides ( a ( full history ) ) ) ( during interview ) ) )

23edf5e6-66c7-11e7-8b83-f45c89b91419

neutral

She does not answer ROS questions at this time.

She is agitated

(ROOT (S (NP (PRP She)) (VP (VBZ does) (RB not) (VP (VB answer) (NP (NN ROS) (NNS questions)) (PP (IN at) (NP (DT this) (NN time))))) (. .)))

(ROOT (S (NP (PRP She)) (VP (VBZ is) (VP (VBN agitated)))))

( She ( ( ( does not ) ( ( answer ( ROS questions ) ) ( at ( this time ) ) ) ) . ) )

( She ( is agitated ) )

23edfa1e-66c7-11e7-a435-f45c89b91419

entailment

44 yo male presents with multiple stab wounds over left chest and flank with diaphragmatic injury and liver laceration.

Patient presenting with penetrating trauma

(ROOT (NP (NP (NP (CD 44) (NN yo) (JJ male) (NNS presents)) (PP (IN with) (NP (NP (JJ multiple) (NN stab) (NNS wounds)) (PP (IN over) (NP (NP (NP (JJ left) (NN chest)) (CC and) (NP (NN flank))) (PP (IN with) (NP (NP (JJ diaphragmatic) (NN injury)) (CC and) (NP (NN liver) (NN laceration))))))))) (. .)))

(ROOT (NP (NP (NN Patient)) (VP (VBG presenting) (PP (IN with) (NP (VBG penetrating) (NN trauma))))))

( ( ( 44 ( yo ( male presents ) ) ) ( with ( ( multiple ( stab wounds ) ) ( over ( ( ( ( left chest ) and ) flank ) ( with ( ( ( diaphragmatic injury ) and ) ( liver laceration ) ) ) ) ) ) ) ) . )

( Patient ( presenting ( with ( penetrating trauma ) ) ) )

23edfe1a-66c7-11e7-8957-f45c89b91419

contradiction

44 yo male presents with multiple stab wounds over left chest and flank with diaphragmatic injury and liver laceration.

Patient presents with no wounds

(ROOT (NP (NP (NP (CD 44) (NN yo) (JJ male) (NNS presents)) (PP (IN with) (NP (NP (JJ multiple) (NN stab) (NNS wounds)) (PP (IN over) (NP (NP (NP (JJ left) (NN chest)) (CC and) (NP (NN flank))) (PP (IN with) (NP (NP (JJ diaphragmatic) (NN injury)) (CC and) (NP (NN liver) (NN laceration))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBZ presents) (PP (IN with) (NP (DT no) (NNS wounds))))))

( ( ( 44 ( yo ( male presents ) ) ) ( with ( ( multiple ( stab wounds ) ) ( over ( ( ( ( left chest ) and ) flank ) ( with ( ( ( diaphragmatic injury ) and ) ( liver laceration ) ) ) ) ) ) ) ) . )

( Patient ( presents ( with ( no wounds ) ) ) )

23ee01da-66c7-11e7-9ac1-f45c89b91419

neutral

44 yo male presents with multiple stab wounds over left chest and flank with diaphragmatic injury and liver laceration.

Patient received blood transfusion

(ROOT (NP (NP (NP (CD 44) (NN yo) (JJ male) (NNS presents)) (PP (IN with) (NP (NP (JJ multiple) (NN stab) (NNS wounds)) (PP (IN over) (NP (NP (NP (JJ left) (NN chest)) (CC and) (NP (NN flank))) (PP (IN with) (NP (NP (JJ diaphragmatic) (NN injury)) (CC and) (NP (NN liver) (NN laceration))))))))) (. .)))

(ROOT (S (NP (NN Patient)) (VP (VBD received) (NP (NN blood) (NN transfusion)))))

( ( ( 44 ( yo ( male presents ) ) ) ( with ( ( multiple ( stab wounds ) ) ( over ( ( ( ( left chest ) and ) flank ) ( with ( ( ( diaphragmatic injury ) and ) ( liver laceration ) ) ) ) ) ) ) ) . )

( Patient ( received ( blood transfusion ) ) )

23ee0574-66c7-11e7-8799-f45c89b91419

entailment

IVDU on methadone 5.

The patient receives methadone to supplement the opiate cravings.

(ROOT (NP (NP (NP (NN IVDU)) (PP (IN on) (NP (NN methadone) (CD 5)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ receives) (NP (NN methadone)) (S (VP (TO to) (VP (VB supplement) (NP (DT the) (JJ opiate) (NNS cravings)))))) (. .)))

( ( IVDU ( on ( methadone 5 ) ) ) . )

( ( The patient ) ( ( ( receives methadone ) ( to ( supplement ( the ( opiate cravings ) ) ) ) ) . ) )

23ee08b8-66c7-11e7-961a-f45c89b91419

contradiction

IVDU on methadone 5.

The patient takes no medication.

(ROOT (NP (NP (NP (NN IVDU)) (PP (IN on) (NP (NN methadone) (CD 5)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ takes) (NP (DT no) (NN medication))) (. .)))

( ( IVDU ( on ( methadone 5 ) ) ) . )

( ( The patient ) ( ( takes ( no medication ) ) . ) )

23ee0b30-66c7-11e7-aac0-f45c89b91419

neutral

IVDU on methadone 5.

The patient had hepatitis C.

(ROOT (NP (NP (NP (NN IVDU)) (PP (IN on) (NP (NN methadone) (CD 5)))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NNP hepatitis) (NNP C.)))))

( ( IVDU ( on ( methadone 5 ) ) ) . )

( ( The patient ) ( had ( hepatitis C. ) ) )

23ee10b4-66c7-11e7-b754-f45c89b91419

entailment

Transient ischemic attack in [**2524**].

the patient has a history of TIA

(ROOT (NP (NP (JJ Transient) (JJ ischemic) (NN attack)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2524)) (X (SYM **))) (-RRB- -RSB-))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNP TIA)))))))

( ( ( Transient ( ischemic attack ) ) ( in ( -LSB- ( ( ** ( 2524 ** ) ) -RSB- ) ) ) ) . )

( ( the patient ) ( has ( ( a history ) ( of TIA ) ) ) )

23ee1d1e-66c7-11e7-8d57-f45c89b91419

contradiction

Transient ischemic attack in [**2524**].

the patient has no neurologic history

(ROOT (NP (NP (JJ Transient) (JJ ischemic) (NN attack)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2524)) (X (SYM **))) (-RRB- -RSB-))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (DT no) (JJ neurologic) (NN history)))))

( ( ( Transient ( ischemic attack ) ) ( in ( -LSB- ( ( ** ( 2524 ** ) ) -RSB- ) ) ) ) . )

( ( the patient ) ( has ( no ( neurologic history ) ) ) )

23ee1f62-66c7-11e7-88ba-f45c89b91419

neutral

Transient ischemic attack in [**2524**].

the patient has no neurologic deficit

(ROOT (NP (NP (JJ Transient) (JJ ischemic) (NN attack)) (PP (IN in) (PRN (-LRB- -LSB-) (FRAG (SYM **) (QP (CD 2524)) (X (SYM **))) (-RRB- -RSB-))) (. .)))

(ROOT (S (NP (DT the) (NN patient)) (VP (VBZ has) (NP (DT no) (JJ neurologic) (NN deficit)))))

( ( ( Transient ( ischemic attack ) ) ( in ( -LSB- ( ( ** ( 2524 ** ) ) -RSB- ) ) ) ) . )

( ( the patient ) ( has ( no ( neurologic deficit ) ) ) )

23ee22fa-66c7-11e7-8117-f45c89b91419

entailment

X-ray revealed an unusual opacity in the left lateral aspect of the left upper lobe and lucency medially.

The patient has a finding of possible pneumonia.

(ROOT (S (NP (NN X-ray)) (VP (VBD revealed) (NP (NP (DT an) (JJ unusual) (NN opacity)) (PP (IN in) (NP (NP (DT the) (JJ left) (JJ lateral) (NN aspect)) (PP (IN of) (NP (NP (DT the) (JJ left) (JJ upper) (NN lobe)) (CC and) (NP (NN lucency))))))) (ADVP (RB medially))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (NP (DT a) (NN finding)) (PP (IN of) (NP (JJ possible) (NN pneumonia))))) (. .)))

( X-ray ( ( ( revealed ( ( an ( unusual opacity ) ) ( in ( ( the ( left ( lateral aspect ) ) ) ( of ( ( ( the ( left ( upper lobe ) ) ) and ) lucency ) ) ) ) ) ) medially ) . ) )

( ( The patient ) ( ( has ( ( a finding ) ( of ( possible pneumonia ) ) ) ) . ) )

23ee2522-66c7-11e7-894f-f45c89b91419

contradiction

X-ray revealed an unusual opacity in the left lateral aspect of the left upper lobe and lucency medially.

The patient has a clear chest X-ray.

(ROOT (S (NP (NN X-ray)) (VP (VBD revealed) (NP (NP (DT an) (JJ unusual) (NN opacity)) (PP (IN in) (NP (NP (DT the) (JJ left) (JJ lateral) (NN aspect)) (PP (IN of) (NP (NP (DT the) (JJ left) (JJ upper) (NN lobe)) (CC and) (NP (NN lucency))))))) (ADVP (RB medially))) (. .)))

(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ has) (NP (DT a) (JJ clear) (NN chest) (NN X-ray))) (. .)))

( X-ray ( ( ( revealed ( ( an ( unusual opacity ) ) ( in ( ( the ( left ( lateral aspect ) ) ) ( of ( ( ( the ( left ( upper lobe ) ) ) and ) lucency ) ) ) ) ) ) medially ) . ) )

( ( The patient ) ( ( has ( a ( clear ( chest X-ray ) ) ) ) . ) )